Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,19793,128,1.69 [0.64-4.46],0.2926477055947788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,19265,126,0.98 [0.71-1.34],0.8800763859251467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,22592,141,0.95 [0.73-1.24],0.7233562237567874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,19161,122,1.12 [0.70-1.77],0.6402746287677501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,22468,142,1.08 [0.84-1.39],0.5589748335575848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,22592,141,1.00 [0.80-1.25],0.988050330760105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,19769,129,1.12 [1.00-1.26],0.0449568765185793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,19161,122,0.99 [0.76-1.28],0.9141775970860002
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22182,139,1.09 [0.91-1.30],0.3594957762239351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19389,130,0.83 [0.62-1.10],0.1866931797539955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19767,131,1.18 [0.99-1.41],0.0712503054874426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,22491,141,0.86 [0.51-1.47],0.5852193556827666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,19769,129,1.24 [0.65-2.36],0.5089800425945248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22289,137,1.20 [0.90-1.60],0.2145854531664358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,19352,126,0.72 [0.42-1.25],0.2496964830752253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,19666,129,1.07 [0.92-1.24],0.3790347715042671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22696,142,0.91 [0.67-1.23],0.5392457720432293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19218,129,0.99 [0.68-1.45],0.96582132415373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,22804,142,1.25 [0.80-1.95],0.3318310965605854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,22859,144,1.13 [0.89-1.42],0.3095711802376623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,19662,131,0.91 [0.58-1.43],0.6748219361670291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,19218,129,0.73 [0.44-1.19],0.2047444839868067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19161,122,1.16 [0.78-1.74],0.4712080932748685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22289,137,0.85 [0.58-1.24],0.3936684092831805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,19161,122,0.98 [0.71-1.35],0.8933739849331772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,22268,140,0.89 [0.54-1.47],0.6412956322221095
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,22511,141,1.18 [0.64-2.20],0.5965163151359685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,22696,142,0.86 [0.67-1.11],0.2555415038579227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19161,122,0.88 [0.64-1.22],0.4460837146188526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,19269,126,1.11 [0.86-1.43],0.4341519507806436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,22946,144,1.06 [0.69-1.61],0.7953850782525947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,22537,140,1.10 [0.77-1.57],0.5893352487657237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19218,129,1.40 [0.94-2.09],0.0944957205352661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22289,137,0.88 [0.53-1.45],0.6062084087113695
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22547,142,1.69 [1.10-2.59],0.0166046516006078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22946,144,1.32 [0.85-2.06],0.2127791102889575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22858,145,1.48 [0.88-2.50],0.1437498045895336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19666,129,1.00 [0.57-1.78],0.98862264208594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19218,129,1.03 [0.60-1.77],0.9092013752265214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22967,143,1.13 [0.59-2.16],0.7225226097633375
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22592,141,1.10 [0.78-1.55],0.5974837655402043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22289,137,0.75 [0.43-1.32],0.3189978532755707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19218,129,0.70 [0.42-1.16],0.1642928238437484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22768,145,0.96 [0.69-1.34],0.8292445752904747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,19762,130,1.16 [0.68-1.97],0.5847248468314494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,19265,126,1.26 [0.60-2.64],0.543021714665542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,19767,131,0.79 [0.52-1.22],0.2884849328564564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22182,139,1.07 [0.74-1.55],0.7264156996000081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,19352,126,1.21 [0.95-1.54],0.1274635396340399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,22511,141,1.37 [0.88-2.13],0.1653422515124831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19352,126,0.77 [0.47-1.24],0.2806473433699218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,19666,129,0.94 [0.69-1.29],0.7088619364889008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,22801,144,0.89 [0.52-1.51],0.6551459674681792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,22859,142,1.01 [0.61-1.67],0.98359597275973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,19767,131,1.02 [0.58-1.78],0.953183564516671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,22592,141,1.12 [0.88-1.42],0.3583676250630732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,22696,142,0.68 [0.39-1.18],0.1697253937262678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,19159,128,1.02 [0.81-1.29],0.8386839663096923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,19352,126,0.97 [0.77-1.23],0.8254267619591542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22289,137,1.03 [0.86-1.23],0.7739630982323322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,19793,128,0.96 [0.75-1.24],0.7787621087356227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,22898,144,1.27 [0.73-2.23],0.4027557841043178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,19161,122,0.95 [0.74-1.22],0.6896484227836861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,19352,126,1.03 [0.84-1.26],0.7832079402110925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFM,Afamin,19793,128,1.33 [0.54-3.27],0.5275476346136535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,22484,141,0.98 [0.78-1.21],0.8247516488523641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,19159,128,1.01 [0.84-1.23],0.9056466140219762
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,22649,144,1.42 [1.00-2.02],0.0513143172271165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,21933,136,0.88 [0.75-1.02],0.0805728574539624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,22142,139,0.92 [0.71-1.20],0.5427728683282265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,22801,144,1.19 [0.77-1.85],0.4253305280393391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,22946,144,1.15 [0.87-1.52],0.3273506459354716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,19769,129,1.45 [0.75-2.83],0.271347624034166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,22696,142,1.03 [0.85-1.25],0.7747047668579855
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,22696,142,1.05 [0.85-1.31],0.6262581118249473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,19265,126,0.82 [0.47-1.43],0.4809321620483749
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,19265,126,1.61 [0.95-2.74],0.0774835179777388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19662,131,1.10 [0.88-1.37],0.4025244614516962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,19769,129,1.29 [0.69-2.40],0.4217404024319351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,22671,144,0.93 [0.79-1.10],0.4104983778045589
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",19220,129,1.01 [0.82-1.23],0.9487865179336036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,22182,139,0.98 [0.74-1.31],0.8945560565291999
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,19265,126,1.24 [0.98-1.58],0.0730737118206979
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22547,141,1.10 [0.96-1.27],0.1761783913493853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,22696,142,0.93 [0.74-1.18],0.5662724026680093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",19727,130,1.09 [0.93-1.28],0.2617253822612918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,19352,126,1.01 [0.46-2.23],0.9748872487725656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,22182,139,1.07 [0.88-1.30],0.5155649547033081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,19220,129,0.85 [0.63-1.15],0.2907417897438618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,22289,137,1.21 [0.97-1.51],0.0880899284574686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19218,129,0.90 [0.70-1.17],0.43201879467127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,22131,137,1.05 [0.84-1.32],0.6582244903027066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,19738,132,1.07 [0.93-1.22],0.3412830511968329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,22073,138,0.98 [0.75-1.28],0.8839579774907538
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,22967,143,1.73 [0.81-3.69],0.1576206067831813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,22706,144,0.82 [0.62-1.08],0.1621847187859993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19662,131,1.13 [0.86-1.49],0.3762134531848489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22626,144,0.94 [0.75-1.19],0.6281593047543478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19738,132,1.32 [0.97-1.81],0.0802868197526661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,19389,130,0.87 [0.58-1.29],0.4800860998220554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,19218,129,0.91 [0.79-1.05],0.2037615884274824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",22592,141,1.20 [1.04-1.38],0.0119004512062847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,22268,140,1.35 [0.90-2.04],0.1517760760446213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,22865,144,1.61 [0.77-3.37],0.2043730013160769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19762,130,1.59 [0.83-3.06],0.1657996602401757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,22131,137,1.07 [0.86-1.34],0.5408842461760339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,19220,129,1.06 [0.77-1.47],0.7027730905625882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,22592,141,1.08 [0.56-2.08],0.8288636849475577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,22268,140,1.05 [0.77-1.44],0.7556265832673976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19352,126,1.02 [0.67-1.56],0.9264727755822604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,19604,131,1.01 [0.71-1.42],0.9754674395473912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,19727,130,0.95 [0.75-1.19],0.6477415958740509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18499,125,1.03 [0.73-1.45],0.8736222371896164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,21797,139,1.08 [0.78-1.49],0.631534815583719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,21137,132,1.09 [0.78-1.51],0.6228152018454594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,22611,140,1.17 [0.76-1.79],0.4777725033319318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,22618,143,1.02 [0.86-1.22],0.809264294013559
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22898,144,0.85 [0.57-1.27],0.4271746883555459
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22390,140,0.93 [0.55-1.56],0.7766943861207016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,22733,143,1.39 [0.96-2.00],0.0793476137545055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,22680,141,0.89 [0.59-1.35],0.5931145535135003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,22762,144,1.30 [0.94-1.80],0.10982344979725
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,22898,144,1.03 [0.68-1.54],0.8996730661932378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,19161,122,1.08 [0.86-1.34],0.50817377041858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19218,129,1.05 [0.85-1.30],0.6531415035736202
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,19071,126,1.13 [0.85-1.49],0.4041317991570547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,22182,139,0.83 [0.62-1.10],0.1957581469879588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19265,126,1.37 [1.03-1.84],0.0334850888579597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,22716,141,1.21 [0.72-2.04],0.4624969492883503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,19224,123,0.83 [0.55-1.27],0.3950590218841715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,22131,137,0.99 [0.82-1.19],0.9157923745363036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,22630,145,1.03 [0.83-1.28],0.7941373661427724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,18972,124,1.07 [0.85-1.36],0.5694411856440713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,22858,145,1.01 [0.82-1.25],0.909139646039318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,22580,142,0.98 [0.80-1.21],0.8811285326301957
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,22071,137,0.73 [0.44-1.23],0.2383497853862033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22268,140,1.12 [0.89-1.40],0.3231746291564605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,22757,141,1.12 [0.69-1.83],0.6429918645154049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,19662,131,1.08 [0.88-1.33],0.4404191532395108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,19220,129,1.13 [0.81-1.58],0.4781379249414605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,19666,129,1.14 [0.92-1.42],0.2255905811146188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,19727,130,1.24 [0.88-1.74],0.2215388058809118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22592,141,0.87 [0.61-1.24],0.443332305706639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,19610,126,1.06 [0.65-1.71],0.8205759497852049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22825,144,0.88 [0.68-1.13],0.3190167621227315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,22696,142,0.90 [0.67-1.20],0.457497170429317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,19793,128,0.73 [0.37-1.42],0.3487421111070955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,19769,129,1.14 [0.81-1.61],0.4415675489640145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,19793,128,1.03 [0.65-1.62],0.9012443600687576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,19769,129,2.38 [1.14-4.96],0.0206531411915219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,19265,126,1.25 [0.82-1.90],0.2958468415340441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,19748,127,1.24 [0.79-1.93],0.3521971160071069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,18877,122,1.02 [0.68-1.52],0.926402871093463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,19793,128,1.10 [0.90-1.33],0.3477559059216403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,19769,129,0.76 [0.44-1.29],0.3053483832338353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,22706,144,1.06 [0.70-1.59],0.7955485224679263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,19769,129,0.98 [0.76-1.28],0.890765884834173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,22720,141,1.26 [0.72-2.21],0.4143691385909915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,22672,144,1.00 [0.80-1.24],0.9869627020651588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,19352,126,0.99 [0.85-1.15],0.8859793449773623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,22517,142,1.10 [0.81-1.51],0.53291065391933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,19389,130,0.93 [0.72-1.20],0.5639952387746161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,22592,141,1.31 [0.98-1.76],0.0722572399233538
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,19666,129,1.03 [0.87-1.21],0.7439181447958306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,19738,132,1.13 [0.89-1.43],0.3345403158677776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,22602,143,0.76 [0.58-1.00],0.0521389557981678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",19662,131,0.81 [0.53-1.23],0.3182842778558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,22182,139,1.19 [0.86-1.66],0.2963530718609178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,22182,139,0.95 [0.73-1.23],0.6972416639844228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,19389,130,1.18 [0.80-1.75],0.4079235543092419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,19352,126,1.01 [0.82-1.25],0.9024894526626605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,19071,126,0.94 [0.75-1.18],0.5891653827815981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,19727,130,1.11 [0.92-1.33],0.2946738941343064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,19738,132,0.96 [0.80-1.15],0.6884154777321102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,22660,145,1.03 [0.89-1.19],0.7077233660424866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,19159,128,0.93 [0.73-1.18],0.5594490441107765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,19159,128,0.68 [0.43-1.08],0.1039353506073383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,22131,137,0.89 [0.61-1.32],0.5664582947605639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,19161,122,1.01 [0.79-1.30],0.9281850993326196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19161,122,1.13 [0.74-1.73],0.5600330968311064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,19159,128,1.12 [0.89-1.41],0.3379060770275528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,22268,140,0.66 [0.41-1.05],0.0820667796507545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19161,122,0.87 [0.60-1.25],0.4532122498828738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,22706,144,0.96 [0.69-1.35],0.8252959962708153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,22592,141,0.99 [0.75-1.30],0.9360501319025064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,22757,141,1.43 [0.91-2.24],0.119354108464175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,19159,128,0.97 [0.74-1.27],0.8486535704894294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,22268,140,0.96 [0.68-1.35],0.8164416204947446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,19579,130,1.03 [0.73-1.47],0.8525523263770864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,22547,142,1.06 [0.80-1.43],0.6726970210607216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,22547,142,1.47 [0.89-2.42],0.1289961292493899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,19769,129,1.64 [0.88-3.04],0.1193695594210484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,19767,131,1.17 [0.66-2.08],0.5841914714292067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,19738,132,1.05 [0.82-1.34],0.7080460807790986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19265,126,1.04 [0.88-1.23],0.665148878567245
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,19161,122,0.97 [0.78-1.21],0.7987410356010383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22131,137,0.91 [0.70-1.16],0.4386801221245706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,19071,126,1.29 [0.83-1.99],0.2585067048460823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,19666,129,1.02 [0.84-1.25],0.8393228369708918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,22182,139,0.88 [0.68-1.14],0.3248235413515909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,22768,145,1.05 [0.85-1.29],0.6455247294032882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19161,122,0.99 [0.69-1.42],0.9547815990040788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19161,122,1.12 [0.66-1.90],0.6848443116728626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19161,122,0.87 [0.54-1.39],0.5588932380990026
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,19071,126,1.29 [0.91-1.84],0.1554771487744684
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19161,122,0.91 [0.67-1.23],0.546511589513255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19161,122,1.11 [0.85-1.47],0.4382445589906741
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",22801,144,1.03 [0.90-1.17],0.7027091730955757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",22131,137,0.98 [0.68-1.41],0.903229268140654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,22182,139,1.23 [0.91-1.67],0.1872792632546638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,22592,141,1.30 [0.78-2.16],0.3228459203598993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,22083,137,1.11 [0.89-1.39],0.3542177140897803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,19265,126,1.08 [0.85-1.36],0.5346106644245738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,19161,122,0.87 [0.72-1.04],0.1304934661014271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,19666,129,1.14 [0.68-1.89],0.6178860703992164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",19793,128,1.68 [0.60-4.66],0.321280955088645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,22131,137,1.08 [0.88-1.34],0.459341538057797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,19159,128,1.05 [0.91-1.21],0.4999429114139706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,19738,132,0.98 [0.69-1.40],0.9233893464408928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,19727,130,1.03 [0.79-1.35],0.8024656599697588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,22660,145,1.02 [0.87-1.20],0.77403954720755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,22757,141,1.10 [0.63-1.90],0.7413594710526834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,19738,132,0.92 [0.68-1.25],0.5896031025111066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,21970,134,0.93 [0.76-1.14],0.5104060173791474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,19793,128,0.70 [0.38-1.30],0.2569920486483896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19161,122,0.61 [0.25-1.51],0.2874133564463996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19265,126,1.10 [0.69-1.77],0.6866482703296646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",22801,144,1.48 [0.87-2.53],0.1506633453566774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22706,144,0.84 [0.46-1.56],0.587694910659627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,19218,129,1.05 [0.60-1.86],0.8635526050968292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,22660,145,1.04 [0.85-1.27],0.7059509416028711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,22511,141,1.01 [0.69-1.47],0.95342278166894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,19218,129,1.21 [0.88-1.67],0.2387561135866765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,22289,137,0.81 [0.53-1.25],0.3359637426552299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22182,139,1.14 [0.90-1.44],0.2670735873770608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22182,139,1.05 [0.63-1.76],0.8445921838176528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,22660,145,1.00 [0.87-1.15],0.9698044148828664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,19727,130,0.97 [0.75-1.25],0.7955649243202978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,19220,129,1.06 [0.89-1.27],0.5202295619149562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,22101,137,1.08 [0.91-1.29],0.3497987965251596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,22706,144,1.61 [0.88-2.94],0.1190614808581479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,22547,142,1.12 [0.72-1.74],0.6201371522074752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19767,131,1.31 [0.79-2.17],0.3006022199977831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19159,128,0.99 [0.72-1.35],0.9378539503752676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,19394,126,0.71 [0.43-1.17],0.1759936111168007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,19666,129,0.87 [0.62-1.23],0.4469086222806346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,19727,130,1.08 [0.91-1.28],0.3529641009391172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22660,145,1.03 [0.74-1.43],0.8647016579554393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,19218,129,0.86 [0.63-1.17],0.3383420062129963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,19071,126,0.94 [0.71-1.25],0.6737084879026549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19662,131,1.04 [0.72-1.49],0.8408962145264649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,22660,145,1.02 [0.87-1.20],0.8202372466417904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,19762,130,0.96 [0.79-1.17],0.6750989653564738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,19265,126,1.06 [0.81-1.41],0.6566532134102456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,19071,126,0.75 [0.49-1.15],0.1890518624328789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,19762,130,1.09 [0.91-1.31],0.3705368575246257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,22143,139,1.06 [0.94-1.20],0.3198538945625198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,19159,128,1.01 [0.80-1.28],0.9234790899629028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19161,122,1.55 [0.80-3.01],0.1975790953602411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,22660,145,1.06 [0.86-1.31],0.6002170614759988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,22706,144,0.97 [0.82-1.14],0.6796715206777448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,22182,139,1.10 [0.87-1.40],0.4298646256746409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,22967,143,0.85 [0.55-1.32],0.4692969996510366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,19218,129,1.17 [0.77-1.77],0.4628457100325591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19159,128,0.98 [0.77-1.24],0.861687991534214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19727,130,1.08 [0.72-1.63],0.7058029474732379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,22706,144,0.90 [0.72-1.12],0.3439780778464989
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19352,126,1.59 [0.87-2.93],0.1346052848686009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,22511,141,1.11 [0.80-1.53],0.5374045840737611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,22252,136,0.99 [0.69-1.43],0.9771379275512456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,19352,126,0.75 [0.35-1.62],0.4690749627251837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19767,131,1.53 [1.00-2.34],0.0476701591645829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19218,129,1.00 [0.68-1.46],0.9953973883015582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,22289,137,0.94 [0.49-1.79],0.8477643191386055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,19159,128,1.32 [1.02-1.72],0.0333880167113176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,19265,126,0.97 [0.71-1.32],0.8392979083225411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,18582,123,0.93 [0.79-1.09],0.3922240165934074
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,22637,141,0.96 [0.75-1.22],0.7178081786489482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,19733,131,1.15 [0.92-1.44],0.2273494458049851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,19496,129,1.01 [0.86-1.18],0.9485934888876768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,19389,130,1.14 [0.69-1.91],0.6062422174350774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,19159,128,1.11 [0.70-1.77],0.6586874660839258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,19161,122,1.04 [0.73-1.47],0.839393872175241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,19161,122,1.35 [0.86-2.11],0.1882023156267653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,22131,137,1.10 [0.78-1.55],0.5956040701655263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,19159,128,0.85 [0.55-1.33],0.4860679426608324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,19738,132,1.14 [0.77-1.70],0.5102292733211559
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BSG,Basigin,22906,144,2.24 [1.06-4.72],0.0342159950612482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BSND,Barttin,19071,126,1.27 [0.80-1.99],0.3082461000361034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22898,145,0.97 [0.72-1.31],0.8445622293573455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,22898,145,0.96 [0.72-1.27],0.7601446295725305
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,22182,139,0.98 [0.80-1.20],0.8568878948313923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,19793,128,1.12 [0.49-2.53],0.7875941239984412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,19071,126,1.09 [0.91-1.29],0.3502441819896019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,19627,131,0.83 [0.53-1.31],0.4289612098370915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,22801,144,1.32 [0.75-2.32],0.3395703014505378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,22660,145,0.90 [0.61-1.34],0.6089588244425709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,19071,126,1.01 [0.66-1.53],0.9748035597135924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,22131,137,0.99 [0.77-1.26],0.9303574643070408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,19161,122,1.07 [0.63-1.84],0.7958862639911275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,22829,144,0.96 [0.50-1.85],0.9076826561088228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19738,132,0.97 [0.76-1.23],0.7811086547150936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,19218,129,1.14 [0.80-1.64],0.4671998337494393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22757,141,1.14 [0.81-1.60],0.4594327207265462
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19352,126,1.16 [0.73-1.83],0.5237309098035015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19738,132,0.93 [0.55-1.56],0.7714484239302334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19310,126,0.65 [0.48-0.89],0.0074087394220324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,19793,128,1.08 [0.46-2.52],0.865765474071121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,19761,128,1.08 [0.45-2.56],0.8688769534147657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,19793,128,1.12 [0.50-2.51],0.7849338300732805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2,Complement C2,22720,141,0.88 [0.50-1.56],0.661590032464499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,22083,137,1.22 [0.90-1.66],0.1907607960687806
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,19220,129,1.16 [0.91-1.49],0.2394804331022406
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C3,Complement C3,18779,117,1.30 [0.95-1.78],0.0950766877774076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,22768,145,0.75 [0.53-1.08],0.1251109404941625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C5,Complement C5,19793,128,0.71 [0.22-2.21],0.5505373106117784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19310,120,0.79 [0.45-1.37],0.3957481128429752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,19727,130,1.02 [0.50-2.08],0.956379931777478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,19793,128,0.70 [0.41-1.20],0.1970538206010521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,19769,129,0.98 [0.70-1.38],0.9100909541069832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,19666,129,0.89 [0.73-1.10],0.2819641402155637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,22160,138,0.84 [0.66-1.07],0.1510321205231017
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,22182,139,0.96 [0.60-1.54],0.8718991775385966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,22592,141,1.63 [1.07-2.49],0.0235412178054031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,22457,141,1.02 [0.89-1.18],0.7408943753341757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,22898,144,0.84 [0.54-1.29],0.4182963404704868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,22630,144,0.87 [0.71-1.08],0.205021879848895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,22928,143,0.90 [0.71-1.15],0.4110412207422146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,22967,143,1.36 [0.73-2.55],0.3314321847422492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",22289,137,1.00 [0.85-1.18],0.9967557679335938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,22633,143,0.90 [0.71-1.14],0.3868575112210584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,19389,130,0.89 [0.54-1.47],0.6487218854250443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,19218,129,1.20 [0.74-1.95],0.4604167746203583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,22898,144,1.19 [0.87-1.62],0.2845537756126799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,19220,129,1.14 [0.89-1.45],0.2998707168064931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19159,128,1.47 [0.98-2.19],0.0609250575174639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19161,122,0.99 [0.74-1.33],0.9386718260579427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19159,128,0.92 [0.68-1.24],0.5923741129893179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19738,132,1.14 [0.94-1.39],0.1950321566639116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,19309,126,1.06 [0.90-1.26],0.4797817347088673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,19220,129,0.88 [0.57-1.34],0.5411078209896198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,22592,141,1.42 [0.99-2.05],0.0586566487948251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,22131,137,0.99 [0.61-1.63],0.981301926061204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,22499,142,1.24 [0.97-1.58],0.0817778689047719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,19727,130,1.16 [0.80-1.70],0.4372966743066997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22825,144,0.97 [0.84-1.12],0.7284584079448303
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19265,126,1.06 [0.85-1.32],0.5901496474466851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,19161,122,1.20 [0.82-1.77],0.3487876712881823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22182,139,0.85 [0.60-1.22],0.3844524913115477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19220,129,1.01 [0.74-1.37],0.9565605261282568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19738,132,1.03 [0.88-1.20],0.747253201133047
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,22630,142,1.02 [0.49-2.13],0.952003344731525
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,22544,143,1.03 [0.80-1.33],0.8258987074416352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,19662,131,1.13 [0.75-1.69],0.5581164410401702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,19727,130,1.00 [0.84-1.18],0.9665005568923236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,22131,137,0.94 [0.70-1.25],0.6539256004405918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,19220,129,1.19 [0.80-1.78],0.3792453314668578
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,22131,137,0.86 [0.68-1.08],0.2031065138449743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,22131,137,1.01 [0.82-1.25],0.9253594824152728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,22660,145,1.02 [0.82-1.26],0.8741656558846976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,22967,143,1.01 [0.85-1.20],0.9090899780441446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,19389,130,0.96 [0.87-1.07],0.465957483961483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,19727,130,1.07 [0.88-1.31],0.4968847594781006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,22826,144,0.99 [0.79-1.26],0.9600290103775664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,19218,129,1.12 [0.86-1.46],0.385259542180577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,19161,122,1.18 [0.88-1.59],0.2662595953596628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAT,Catalase,19465,127,0.88 [0.65-1.21],0.4391808480647932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,22662,142,1.11 [0.91-1.36],0.2921448503479718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,19159,128,1.04 [0.89-1.23],0.6223787671984812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,22898,144,1.23 [0.78-1.95],0.3687158588343011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,19265,126,1.25 [0.93-1.69],0.144365048093596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,19161,122,0.94 [0.60-1.46],0.7691760981622486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22547,142,0.99 [0.81-1.21],0.9357027587923776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,19727,130,0.88 [0.62-1.24],0.4635436519729142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,19662,131,1.09 [0.79-1.52],0.5918545049241015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,19220,129,0.78 [0.44-1.40],0.406133110871819
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,19738,132,0.86 [0.68-1.09],0.2171120643561732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,22696,142,1.23 [0.82-1.85],0.3208481474311002
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19265,126,1.36 [1.06-1.75],0.0174722987488035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,22946,144,0.81 [0.55-1.20],0.2921299318309636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,22906,144,0.90 [0.72-1.11],0.3124176190640195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,22611,140,1.19 [0.82-1.71],0.3662731519670006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,22967,143,1.10 [0.79-1.54],0.5724275265060803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,22967,143,1.04 [0.78-1.38],0.7929064295274494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,22665,143,0.84 [0.71-0.99],0.0337599078802617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,22346,139,0.95 [0.76-1.19],0.6657038328388236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,22898,145,1.02 [0.92-1.13],0.7254771943802221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,22511,141,0.89 [0.67-1.18],0.4005782074663785
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,22946,144,0.93 [0.78-1.11],0.4084512236596728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,22801,144,0.98 [0.69-1.38],0.8867184396636301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,22474,143,1.13 [0.85-1.50],0.3888144878291423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,22801,144,1.21 [0.85-1.72],0.2959133577678752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,22762,144,0.99 [0.83-1.19],0.945370155168748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,22946,144,0.95 [0.70-1.29],0.7280623998974065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,22660,145,0.90 [0.76-1.07],0.2339993278427085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,22696,142,1.03 [0.80-1.32],0.8392626890928238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,22584,144,0.95 [0.74-1.23],0.7122549277848866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,22660,145,1.06 [0.85-1.32],0.5909932262828077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,22732,143,0.98 [0.79-1.21],0.8248606718856004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,22757,141,1.07 [0.92-1.23],0.3934821138239599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22660,145,1.02 [0.80-1.30],0.8912357674023784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,22865,144,0.92 [0.73-1.17],0.5206982432378012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,22552,141,1.06 [0.87-1.29],0.5631269471125867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,22689,144,0.88 [0.68-1.13],0.3166344687006661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,22934,143,1.06 [0.68-1.65],0.7976146514174058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,22898,144,1.15 [0.81-1.63],0.4333024263365721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,22706,144,1.35 [0.94-1.95],0.1087210746216485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,19389,130,1.06 [0.67-1.68],0.7922428033910575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,19218,129,0.88 [0.70-1.11],0.2901794668278554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,22547,142,0.92 [0.67-1.25],0.5756203452585826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,22182,139,1.01 [0.73-1.41],0.93543450156187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,19666,129,0.85 [0.58-1.25],0.4081362319793109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,22706,144,1.26 [0.81-1.97],0.3106529057813813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22193,139,1.10 [0.76-1.58],0.6128147846219445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,22946,144,1.13 [0.82-1.55],0.451256885361774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22757,141,1.14 [0.81-1.61],0.4649690191662642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,22706,144,1.16 [0.69-1.94],0.5813318721731757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,19220,129,1.19 [0.77-1.84],0.4322354761124763
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,22677,144,0.99 [0.88-1.10],0.8092171229778873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,22768,145,1.26 [0.68-2.35],0.4665690302742045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,19161,122,1.10 [0.73-1.66],0.6528248063797837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,22660,145,1.36 [0.76-2.41],0.2987403275969895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,22592,145,0.73 [0.47-1.13],0.157186964915302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,22200,141,1.14 [0.77-1.68],0.5105053263762334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,22743,142,0.90 [0.62-1.32],0.5928942051363715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,22946,144,1.34 [0.93-1.91],0.1137289155854991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,19218,129,1.17 [0.78-1.75],0.4392799844814649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,22946,144,1.54 [0.90-2.65],0.1135984114931782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,19762,130,1.11 [0.73-1.69],0.6113923300147512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,22768,145,1.14 [0.79-1.64],0.4836281570444427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,22547,142,1.27 [0.84-1.92],0.2575875272126943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,22692,144,1.26 [0.83-1.91],0.2832747754672586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,22182,139,0.90 [0.59-1.38],0.6341168372162623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,22696,142,1.03 [0.82-1.30],0.7881375245047713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,19352,126,1.15 [0.65-2.04],0.6397366763859276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,22898,145,1.32 [0.87-2.01],0.1953482671669801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,22819,144,1.04 [0.72-1.51],0.8195781462107449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,22898,144,0.88 [0.70-1.11],0.2758534003799011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,22706,144,1.08 [0.73-1.60],0.7154663875587269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,22592,141,0.91 [0.55-1.52],0.7294295298313005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,22768,145,0.95 [0.80-1.14],0.5916713854770972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,22816,145,1.37 [0.75-2.52],0.3076597382307052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,19218,129,1.25 [0.86-1.81],0.2344634049459796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22592,141,0.92 [0.57-1.51],0.7513203542830893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,19159,128,1.00 [0.60-1.66],0.9904196476034142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19389,130,0.98 [0.62-1.57],0.938841223198633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,19218,129,1.09 [0.93-1.28],0.2819289575645978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,22618,145,1.02 [0.63-1.64],0.9423806959079264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,22693,143,1.09 [0.81-1.47],0.5536619201977682
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,22946,144,1.03 [0.85-1.25],0.7395985036291687
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,22530,140,1.45 [0.88-2.38],0.145594347386912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,22762,144,0.70 [0.42-1.15],0.1606016663758605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,22865,144,1.32 [0.85-2.06],0.2190474478515233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,21879,134,1.33 [0.75-2.34],0.3283525367874416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,22658,144,0.79 [0.34-1.80],0.5706836509865875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,21857,138,1.29 [0.67-2.51],0.4443860415186379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,19675,127,0.95 [0.65-1.37],0.7642005680439194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,22906,144,1.00 [0.76-1.32],0.9837373024416268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,22511,141,1.06 [0.80-1.42],0.677296882779562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,22598,141,1.00 [0.84-1.18],0.9850125031186104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,19179,129,1.34 [0.92-1.93],0.1224584273125374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,22660,145,1.17 [0.82-1.66],0.3873809883208449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19352,126,0.98 [0.65-1.47],0.906031969840472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,22898,145,1.12 [0.73-1.70],0.6125088251764099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,22946,144,1.03 [0.73-1.46],0.8570299094669085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,19767,131,1.20 [0.73-1.97],0.4636256807667702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,19389,130,0.98 [0.65-1.47],0.9085743599251463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,22660,145,0.96 [0.62-1.49],0.8547462859858734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,22660,145,1.14 [0.71-1.84],0.5799390579332924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,19666,129,0.88 [0.49-1.59],0.67585620189537
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,22898,145,0.92 [0.68-1.25],0.609857579144374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,21807,137,1.19 [0.73-1.94],0.4829407870173987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,22706,144,0.70 [0.32-1.53],0.3732390406275737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,22706,144,1.23 [0.66-2.30],0.5105031666167663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,19726,131,1.08 [0.77-1.53],0.654957260170119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,19727,130,1.08 [0.55-2.11],0.825779613621926
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,19071,126,0.82 [0.60-1.11],0.1992001722155124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,19071,126,0.73 [0.45-1.17],0.1886999045012037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,19638,129,1.12 [0.89-1.42],0.3374081910862428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,22182,139,0.84 [0.64-1.09],0.1854063927464555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,22768,145,1.06 [0.89-1.26],0.5343192670592449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19666,129,1.03 [0.87-1.21],0.733492286751741
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22547,142,1.12 [0.83-1.51],0.4502390690931077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,21902,132,1.03 [0.69-1.51],0.9004579815578992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,22850,145,1.29 [0.97-1.72],0.0848917630943728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,22696,142,0.85 [0.68-1.07],0.1612387694018227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,22696,142,1.33 [0.88-2.03],0.178526547737633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,19389,130,1.59 [1.01-2.49],0.0436853193499729
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,19727,130,0.94 [0.49-1.79],0.8499439898152024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,22898,145,2.03 [1.43-2.88],7.820258570019174e-05
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,19159,128,0.87 [0.59-1.27],0.4670235422803508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,22967,143,0.81 [0.49-1.34],0.4141766266556368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,22696,142,1.50 [1.02-2.20],0.0407862862253813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,22131,137,1.21 [0.88-1.67],0.2461665100978046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,22592,141,0.95 [0.78-1.16],0.61623048242863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,22696,142,1.02 [0.69-1.49],0.9389045392390912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,19071,126,1.22 [0.77-1.94],0.3910237730356596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19738,132,1.33 [1.03-1.71],0.0281289685054521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,19159,128,0.96 [0.69-1.32],0.7826205302799514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,22592,141,0.99 [0.86-1.14],0.8510369225841542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22592,141,1.03 [0.88-1.21],0.7370388652462423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,22592,141,1.04 [0.65-1.66],0.8711557139466218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22734,144,0.98 [0.56-1.71],0.9324583229512892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,22865,143,1.07 [0.76-1.51],0.6803995268237117
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22729,144,0.85 [0.46-1.57],0.5987458288209058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19666,129,0.95 [0.76-1.17],0.6134835598387286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19389,130,0.98 [0.77-1.26],0.8844246092436507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19666,129,1.05 [0.69-1.60],0.8102020514759972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19389,130,0.99 [0.68-1.44],0.9409981546228016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22660,145,0.97 [0.82-1.15],0.7266147248430828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22182,139,1.20 [0.91-1.59],0.2030611274165588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21878,137,1.07 [0.85-1.35],0.5532911454001876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19762,130,1.37 [0.91-2.06],0.1337282905025483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22289,137,1.18 [0.88-1.58],0.2619760858148551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,19218,129,0.96 [0.61-1.52],0.8597832141021297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,22289,137,0.94 [0.63-1.41],0.7772953101267458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,19762,130,0.96 [0.72-1.27],0.7718282635718817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,22929,143,0.88 [0.67-1.14],0.3203710904696283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19352,126,1.03 [0.57-1.87],0.9278486628347996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,19218,129,1.67 [1.34-2.10],7.481466708221924e-06
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,19159,128,1.13 [0.88-1.44],0.3444909098199348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,19389,130,0.95 [0.69-1.29],0.7257835463401481
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,19389,130,0.92 [0.71-1.18],0.5014579520229832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,19161,122,0.91 [0.59-1.39],0.6501027434624478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,19071,126,1.04 [0.70-1.54],0.840757234923329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,22268,140,0.82 [0.61-1.09],0.1771295584419725
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,19265,126,1.04 [0.84-1.30],0.6977891772042033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,22182,139,1.11 [0.91-1.36],0.298177523962662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,19389,130,0.96 [0.69-1.33],0.8128717020306052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,19071,126,1.01 [0.64-1.59],0.9671284897226028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,22112,136,1.03 [0.82-1.28],0.8245174314066127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,22182,139,0.99 [0.78-1.26],0.9517730385742812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,22131,137,1.16 [0.90-1.48],0.2476944839166825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,22742,143,1.14 [0.95-1.37],0.1523527387779595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,22592,141,0.93 [0.70-1.22],0.5891583749030858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,22592,141,1.09 [0.89-1.33],0.4159633227013205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,22131,137,1.05 [0.84-1.31],0.6610855331899619
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,19666,129,1.12 [0.90-1.39],0.3201514505329286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,19414,124,1.06 [0.63-1.80],0.8197746173136625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,22182,139,1.05 [0.76-1.46],0.7727199312224426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,19793,128,1.36 [0.59-3.11],0.4731984220761803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,18618,116,1.66 [0.77-3.55],0.1955154516468737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,19651,128,1.05 [0.78-1.41],0.7659572840176412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,19761,127,0.96 [0.77-1.21],0.7493696506626504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,19501,127,1.01 [0.67-1.52],0.9624306013337556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,19793,128,1.17 [0.51-2.71],0.7108080982564664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFP,Properdin,19793,128,1.14 [0.56-2.34],0.7220915887238946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,22706,144,1.02 [0.85-1.23],0.8126232688104211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19769,129,1.02 [0.68-1.52],0.9404089827288522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,19220,129,1.31 [0.95-1.81],0.0975326954951995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,22696,142,1.29 [0.91-1.83],0.1480116041460114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22182,139,0.81 [0.62-1.05],0.1117006180258945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,19352,126,0.94 [0.68-1.28],0.6796900619657117
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19727,130,1.04 [0.68-1.60],0.8538517805947237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,19662,131,1.03 [0.58-1.84],0.9189906384994168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,22289,137,0.82 [0.52-1.30],0.3948697949731081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,19762,130,1.17 [1.00-1.38],0.0542588154860483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,22807,145,1.40 [0.97-2.02],0.0683181810843005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,22167,139,1.13 [0.94-1.37],0.2020548442892898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,22786,141,1.06 [0.95-1.18],0.3280353809292214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,22720,141,1.22 [0.77-1.95],0.3954417474424146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,19220,129,1.11 [0.84-1.46],0.4560734587402062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,22547,142,0.99 [0.82-1.19],0.8929021324562219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,19767,131,1.06 [0.79-1.43],0.695104845427877
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,19159,128,1.05 [0.85-1.31],0.6310632756963401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,22762,144,1.04 [0.64-1.68],0.8894584297646011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,22696,142,1.35 [1.04-1.76],0.023022604907618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,19220,129,1.24 [0.84-1.83],0.2734987322517997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,22768,145,0.99 [0.79-1.25],0.9537433298035096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,19762,130,0.80 [0.60-1.08],0.1472337070584778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,19389,130,0.79 [0.51-1.21],0.2753666113285065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,19666,129,1.07 [0.90-1.28],0.4406490046922969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19220,129,1.01 [0.70-1.46],0.9680875054007384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,22837,143,1.47 [0.87-2.49],0.150464551474879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,19762,130,0.91 [0.69-1.20],0.5065848528360217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22617,143,0.94 [0.77-1.15],0.5392586874037737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,19071,126,0.89 [0.68-1.15],0.3676721408083171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,22661,142,0.89 [0.70-1.12],0.3092931536664394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,22547,142,1.15 [0.76-1.73],0.5182939655416798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,22658,144,0.86 [0.63-1.17],0.3342690456240429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,19218,129,1.16 [0.52-2.62],0.7140752184750131
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,22706,144,0.93 [0.58-1.49],0.7534011385968665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,22289,137,0.87 [0.54-1.40],0.5709492669511065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,22898,145,1.01 [0.87-1.17],0.9155845076845508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,19220,129,0.93 [0.65-1.33],0.676192443325524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,19315,123,0.85 [0.37-1.93],0.6985339439499734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,22660,145,0.95 [0.62-1.45],0.8061417456706308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,22660,145,0.80 [0.58-1.10],0.1735100196756305
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,22660,145,1.08 [0.85-1.36],0.5424954166341354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,22660,145,1.11 [0.71-1.73],0.6473684941007535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,19723,130,0.98 [0.70-1.39],0.9234150805666376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,22628,141,1.46 [0.88-2.41],0.143746431061743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,22182,139,1.01 [0.73-1.39],0.960185351750475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,22946,144,1.10 [0.84-1.44],0.5053277255276287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,19220,129,0.87 [0.59-1.30],0.4986074293643768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,19220,129,0.57 [0.37-0.88],0.0113376945319177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,19071,126,0.92 [0.62-1.36],0.6633925707888211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,22660,145,1.03 [0.90-1.17],0.6988701055173256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,22898,144,1.65 [0.80-3.40],0.1788587764000213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,19220,129,0.77 [0.45-1.30],0.3224693662255373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22499,142,1.12 [0.96-1.31],0.1456945135996178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,22671,144,1.13 [0.91-1.39],0.2811961141942168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,22083,137,1.18 [0.79-1.75],0.417536299456038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,22131,137,0.94 [0.69-1.26],0.6639980348819778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,22946,144,0.92 [0.63-1.36],0.679422778634547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,19727,130,1.53 [0.94-2.51],0.0869834958043074
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,22289,137,1.09 [0.81-1.48],0.5627219349690966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,19793,128,1.03 [0.62-1.71],0.9051250350497284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,22665,142,1.27 [0.92-1.75],0.1448237020958887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,19767,131,1.11 [0.93-1.33],0.2549524480348195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,19662,131,0.99 [0.81-1.21],0.904351915489399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,22757,141,0.92 [0.67-1.26],0.6026083217208136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19159,128,1.24 [0.98-1.57],0.0766646160869728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19228,126,1.00 [0.80-1.24],0.9935941492434048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,22289,137,1.17 [0.95-1.44],0.1298430192533528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,22592,141,1.08 [0.89-1.32],0.4410646473803097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNST,Consortin,22696,142,1.00 [0.88-1.15],0.9443461795142278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,19159,128,1.13 [0.70-1.85],0.6115689534317326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,22967,143,0.98 [0.58-1.68],0.952599619658368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,22898,144,0.88 [0.64-1.23],0.4684448046366265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,22706,144,1.08 [0.70-1.65],0.7344821808642708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,22706,144,1.11 [0.60-2.05],0.7505543842113098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,22750,145,0.93 [0.63-1.39],0.7284351279206858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,22660,145,1.08 [0.75-1.56],0.6888082014558579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,19220,129,1.04 [0.88-1.22],0.6629660373070488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,19767,131,1.06 [0.74-1.51],0.7543609065549423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,19762,130,1.13 [0.60-2.13],0.7129592254445192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,22790,142,1.26 [0.67-2.40],0.4724162070884108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,22967,143,0.74 [0.43-1.30],0.2953217894392009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,19666,129,0.78 [0.59-1.02],0.0724449157974857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,19220,129,0.91 [0.71-1.15],0.4263880384563822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,19265,126,0.97 [0.78-1.20],0.7672024639266775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,19762,130,0.87 [0.42-1.79],0.699688029343781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,22696,142,0.94 [0.64-1.38],0.7554410256781516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,19358,130,1.17 [0.84-1.64],0.3447357345060065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19352,126,0.99 [0.64-1.52],0.9540245424175018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,22967,143,1.02 [0.66-1.59],0.9159798862198072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,22660,145,0.79 [0.58-1.09],0.1467295072677099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,19389,130,0.76 [0.50-1.16],0.2047604627965587
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,22692,144,1.22 [0.68-2.18],0.5050595061458403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,19265,126,1.03 [0.78-1.36],0.826678973297991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,19662,131,1.20 [0.83-1.74],0.3376411650039558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,22428,139,0.75 [0.48-1.18],0.2129155153593119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,22052,135,0.97 [0.81-1.16],0.754289570254611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',19161,122,1.08 [0.72-1.61],0.7172739866715411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,22131,137,0.91 [0.64-1.29],0.6118273082034161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19265,126,0.91 [0.61-1.36],0.6434670190461693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,22204,134,0.98 [0.82-1.16],0.7852506989064051
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,19159,128,1.03 [0.65-1.63],0.904673187987822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22592,141,1.11 [0.90-1.37],0.322022281451041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,19767,131,1.25 [0.76-2.05],0.3894873562574037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,22967,143,0.95 [0.73-1.22],0.6806218083224584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,22812,145,1.14 [0.92-1.43],0.2357849690865532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,18960,124,1.46 [0.97-2.19],0.0683881865814931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,22967,143,0.97 [0.75-1.26],0.8339458558956859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,19748,127,0.83 [0.39-1.78],0.6313498163225642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,22736,144,0.95 [0.65-1.38],0.7855268212966381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,19071,126,0.86 [0.48-1.53],0.5982204266060807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,22791,145,1.15 [0.76-1.76],0.5059912345337251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19218,129,1.33 [0.76-2.32],0.3125457492257263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,22898,145,0.96 [0.77-1.20],0.7222833529761363
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,19720,130,0.78 [0.51-1.18],0.2395758437859328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,19161,122,1.55 [1.12-2.16],0.0087928822784638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,22870,144,0.98 [0.68-1.40],0.8934894293450604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,22768,145,0.99 [0.80-1.22],0.9314712366471872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,19767,131,1.08 [0.57-2.07],0.8114540580901303
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,19687,128,1.31 [0.81-2.11],0.2660643141889431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,22757,141,1.09 [0.79-1.50],0.6005026973036041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22182,139,0.96 [0.80-1.14],0.6387544695675548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,22499,142,1.03 [0.85-1.25],0.7730598831286793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,19071,126,1.19 [0.92-1.54],0.1861709798958685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,19071,126,1.25 [0.67-2.31],0.4862896596196153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22398,142,1.07 [0.71-1.61],0.7490030842684097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19352,126,1.60 [1.02-2.49],0.0401945608047227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,22762,144,1.15 [0.87-1.52],0.3396871417456444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,22141,139,0.90 [0.75-1.08],0.2434112195296507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,22692,144,1.02 [0.60-1.72],0.9515116909834022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,22289,137,1.05 [0.83-1.32],0.70086058975454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,22801,144,1.56 [0.76-3.19],0.2263433804850289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,22547,142,1.17 [0.79-1.72],0.4257112055357012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,22898,144,1.15 [0.90-1.46],0.2604433351501929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,19588,128,1.30 [0.69-2.43],0.4166222303468275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,22728,144,0.99 [0.87-1.14],0.932150772464634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,22801,144,1.19 [0.67-2.13],0.5469068208118636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,22053,140,1.01 [0.81-1.26],0.9304030305535324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,22967,143,1.02 [0.62-1.69],0.937899700527124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,22547,142,1.02 [0.76-1.37],0.8911815870059473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,19220,129,0.97 [0.68-1.39],0.8854045902499184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,22289,137,1.07 [0.94-1.21],0.3044977642488469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,19767,131,1.10 [0.85-1.42],0.4596051689245312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,19727,130,1.03 [0.83-1.28],0.7640580304664742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,19727,130,0.88 [0.74-1.04],0.1410432959527811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,19159,128,1.02 [0.82-1.26],0.8714886724838652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,19265,126,1.03 [0.86-1.25],0.7341710740527241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,19161,122,1.04 [0.90-1.20],0.5627688596044647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,22801,144,1.50 [0.88-2.54],0.1323322284605992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,19769,129,1.25 [0.81-1.91],0.3095752480373701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19161,122,1.06 [0.65-1.72],0.8285823691422338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22547,142,0.98 [0.77-1.25],0.8702047354185443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,19218,129,1.27 [0.86-1.88],0.2306841705903289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22268,140,0.80 [0.58-1.10],0.1718397260716552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,19218,129,1.13 [0.66-1.94],0.6438047764385112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,19769,129,1.17 [0.74-1.85],0.4944063984495067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,19218,129,1.06 [0.82-1.38],0.6618904949412835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,19738,132,1.11 [0.77-1.60],0.5880085156055116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,19762,130,0.92 [0.55-1.54],0.7518093452627066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,19159,128,1.08 [0.78-1.49],0.6568398700651663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,19161,122,0.95 [0.79-1.15],0.614750610085205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,17150,113,1.05 [0.88-1.26],0.59730264276571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,22724,141,1.09 [0.64-1.85],0.7649142570025012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,22316,142,1.04 [0.80-1.36],0.7616995402585504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,22121,141,1.11 [0.81-1.52],0.5143103403265279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,22732,143,1.08 [0.94-1.25],0.2612784294947057
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,22383,141,1.16 [0.82-1.65],0.3974815733925113
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,19346,130,1.24 [0.92-1.67],0.1601178324531981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,19473,127,0.72 [0.41-1.29],0.2716214594943426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,22289,137,1.08 [0.91-1.29],0.3713370960891793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,19762,130,0.97 [0.53-1.76],0.9120921658943072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,19762,130,0.80 [0.45-1.42],0.440943015249382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,19159,128,1.04 [0.67-1.63],0.8511188684501461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,22706,144,0.97 [0.74-1.28],0.825695717161055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,22700,143,0.90 [0.71-1.13],0.3621752034462021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,19727,130,1.06 [0.82-1.36],0.6724064899619844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,22713,141,1.30 [1.00-1.69],0.0529938127004717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,22656,143,0.96 [0.68-1.36],0.8188149009626652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,21161,127,0.98 [0.65-1.47],0.920863503321711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,19352,126,1.07 [0.77-1.49],0.7025097208398168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,22768,145,0.95 [0.66-1.37],0.781734506390127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,22227,137,1.05 [0.85-1.29],0.6727121887147627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,22696,142,1.10 [0.60-2.04],0.7514095400745907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,22946,144,0.76 [0.46-1.25],0.2780561854039303
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,17830,120,2.24 [1.12-4.47],0.0228070621703516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,22839,144,0.69 [0.48-0.98],0.0404724683649466
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,22678,141,1.12 [0.69-1.81],0.641150347293882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19220,129,1.49 [1.08-2.05],0.0150452041235808
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,19547,128,1.03 [0.79-1.36],0.8106309952191562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,22547,142,1.31 [0.86-2.02],0.2112407525087132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,22660,145,0.86 [0.65-1.15],0.3099099481687121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,22657,143,0.93 [0.79-1.09],0.3561056114396735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,22801,144,0.93 [0.74-1.17],0.5464228631843302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,22898,145,0.83 [0.68-1.01],0.0584212329688994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,22268,140,0.84 [0.58-1.23],0.3645918893189873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,22898,145,1.07 [0.85-1.34],0.5611266670447579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,22268,140,0.99 [0.77-1.27],0.9231340090845424
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,22927,142,1.36 [0.73-2.55],0.3335511291788569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,22946,144,0.75 [0.52-1.07],0.106885553608282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,22693,143,0.97 [0.83-1.13],0.7007133072118567
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,22621,140,0.97 [0.85-1.10],0.6208096154334874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,22946,144,0.93 [0.77-1.12],0.4298036128259541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,22518,139,0.92 [0.73-1.15],0.4584113838932843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,22801,144,0.90 [0.72-1.14],0.390373752831482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,19071,126,0.83 [0.63-1.08],0.1686126232569473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,19424,129,1.00 [0.74-1.36],0.982019590701364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19161,122,1.11 [0.93-1.32],0.2646065037565134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,19071,126,1.10 [0.89-1.37],0.3804132388617395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,19762,130,1.95 [0.97-3.94],0.0610010347612421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,19352,126,1.05 [0.86-1.29],0.6382422401616571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,22898,144,1.08 [0.94-1.23],0.2755903049633265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,22801,144,1.01 [0.74-1.38],0.9386192981270134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,19218,129,0.78 [0.56-1.07],0.1221526647636971
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,19218,129,1.02 [0.75-1.38],0.8976252686959756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22660,145,1.04 [0.91-1.17],0.5840063745878743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22499,142,0.99 [0.81-1.22],0.9521505698807144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,19728,129,1.16 [0.97-1.39],0.1021110597140584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,22606,143,1.02 [0.84-1.23],0.8682497571578434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,19218,129,1.04 [0.74-1.44],0.8354027879331212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,22801,144,1.02 [0.87-1.19],0.830025619710396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22768,145,1.38 [0.91-2.11],0.1319895394912788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,19220,129,1.27 [0.68-2.36],0.4481424218945614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,19071,126,0.87 [0.65-1.16],0.3478742454870879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,19071,126,1.05 [0.61-1.81],0.8596840646683332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCN,Decorin,22289,137,1.45 [0.75-2.78],0.2683135727870931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,19352,126,1.05 [0.88-1.27],0.5773113793600575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,22898,144,1.06 [0.85-1.32],0.6017558728273553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,22592,141,1.06 [0.91-1.24],0.4286506504943141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,22131,137,0.99 [0.80-1.23],0.919036958706748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,22696,142,0.96 [0.60-1.56],0.8838931846908776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,19159,128,1.08 [0.87-1.33],0.4929431485590327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,19071,126,1.00 [0.82-1.23],0.9755864749058486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,22768,145,0.88 [0.66-1.18],0.3902068126833224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,19161,122,1.19 [0.82-1.74],0.3587286807824218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22592,141,1.02 [0.73-1.42],0.9288611134300836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,22662,142,0.77 [0.56-1.04],0.0925437929924867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,19738,132,1.05 [0.82-1.36],0.6934523293303829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,19352,126,0.86 [0.69-1.07],0.1787824337780427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,22898,145,3.26 [1.93-5.50],1.0130760994978656e-05
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,19762,130,0.94 [0.63-1.41],0.7681019398815736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,19666,129,1.18 [0.88-1.57],0.2766349452054355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,19220,129,0.85 [0.53-1.37],0.5069901960685006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,19218,129,0.78 [0.36-1.72],0.5378390841037531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,19218,129,0.98 [0.71-1.34],0.8891443272448221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,19220,129,0.62 [0.38-1.01],0.0563908684080111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,22182,139,0.81 [0.60-1.08],0.1465591756694875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22660,145,1.08 [0.93-1.26],0.3138133881047643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,22209,134,1.23 [0.95-1.59],0.1162791507239252
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,19064,127,0.98 [0.65-1.50],0.9403932075074284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,19159,128,0.71 [0.49-1.03],0.0732084790723036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,19159,128,0.90 [0.71-1.15],0.3955421375548974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,19159,128,0.75 [0.51-1.11],0.145544953902524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,22386,140,0.94 [0.85-1.04],0.2131379906357147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,19161,122,0.99 [0.71-1.38],0.9568659474602174
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,19218,129,1.11 [0.84-1.47],0.4544944311303694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,22946,144,0.99 [0.80-1.23],0.9556361966084218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,19159,128,1.20 [0.87-1.65],0.2635802588765986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,19218,129,1.08 [0.79-1.47],0.6397043722531959
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,22268,140,1.01 [0.66-1.56],0.9555284193164302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,19161,122,0.98 [0.69-1.41],0.9324085551199944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,19662,131,1.04 [0.70-1.54],0.8508631896645928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19727,130,1.24 [0.90-1.71],0.1863690939226415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",22628,141,1.03 [0.90-1.18],0.6596533967918994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,19220,129,1.20 [0.84-1.73],0.3140470043574589
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19352,126,0.93 [0.48-1.79],0.8293612286491915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,22898,145,0.96 [0.75-1.22],0.7268465444866963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,22967,143,1.13 [0.69-1.86],0.6242633525049348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,22516,142,1.57 [1.19-2.07],0.0012696492177297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,22592,141,0.93 [0.79-1.09],0.3815669501408886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,19727,130,1.08 [0.86-1.37],0.4958971546617974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,19738,132,0.83 [0.58-1.21],0.3377816350236817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,22967,143,1.13 [0.86-1.49],0.3848727623746421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,22768,145,1.47 [0.90-2.41],0.1222399206452089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,19265,126,0.91 [0.71-1.17],0.4810081587854987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,19265,126,0.99 [0.71-1.38],0.945075560822835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19265,126,1.13 [0.85-1.50],0.3917333774848556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,19071,126,1.09 [0.77-1.53],0.631986425399323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,22877,143,1.07 [0.89-1.28],0.4619400370439438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,19727,130,1.02 [0.81-1.28],0.8854161173682397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,22592,141,1.02 [0.86-1.20],0.8609727539956402
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,19666,129,1.01 [0.77-1.31],0.958279649801092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,19352,126,0.93 [0.68-1.28],0.660679409396417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,19160,125,1.09 [0.89-1.34],0.4066110404818084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,22289,137,1.01 [0.79-1.31],0.9178992578932288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,19727,130,1.07 [0.69-1.65],0.77240087011615
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19265,126,1.05 [0.86-1.29],0.6084855168241486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,19666,129,1.12 [0.90-1.39],0.3171925336112878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,22659,143,0.92 [0.51-1.68],0.7912275009834193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,19159,128,0.97 [0.81-1.17],0.7472847924000631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,19666,129,1.12 [0.96-1.31],0.1395901115864144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,19738,132,1.05 [0.77-1.41],0.7730829971104339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,22547,142,1.04 [0.82-1.32],0.7538805083032248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,19727,130,1.22 [0.91-1.63],0.189498684239646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22767,144,0.83 [0.63-1.11],0.2058621448732782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,19220,129,1.00 [0.62-1.62],0.9865658566548456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,19159,128,0.87 [0.74-1.03],0.114107296977812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,19727,130,1.03 [0.91-1.17],0.650611104953888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,22696,142,1.03 [0.91-1.16],0.63246430702158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,22499,142,1.13 [0.84-1.51],0.4291062312668422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,22592,141,0.96 [0.57-1.63],0.890957491293109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,22660,145,1.13 [0.74-1.72],0.5614211824258006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22246,138,0.73 [0.44-1.22],0.232345533520157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,22592,141,0.79 [0.51-1.25],0.3208905289935355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,22508,142,1.01 [0.78-1.30],0.961907891355028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,22967,143,0.70 [0.41-1.20],0.1979228973541015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,22825,144,1.08 [0.85-1.37],0.5495439649713671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,22547,142,1.22 [0.87-1.72],0.2455018621800119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,22592,141,0.97 [0.75-1.27],0.8342339660970212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,22457,140,1.11 [0.71-1.74],0.6497147045411025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,19738,132,1.33 [0.83-2.11],0.2334831263941087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,22706,144,1.59 [0.93-2.73],0.0929407947406007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,22830,144,1.21 [0.78-1.87],0.4061432896446337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,22512,141,1.17 [0.88-1.57],0.2821491707815535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,19352,126,1.08 [0.89-1.32],0.4293065477280904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,19634,131,1.29 [0.88-1.88],0.1939902633317932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19220,129,0.88 [0.66-1.17],0.3770267201063346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22592,141,0.97 [0.51-1.83],0.9201957526220618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,19767,131,1.07 [0.84-1.36],0.5757740857198346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,22289,137,1.11 [0.92-1.34],0.2556497372553367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,19662,131,0.88 [0.57-1.34],0.5450230131491768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,19220,129,0.96 [0.74-1.25],0.7855349306133778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,22131,137,1.06 [0.90-1.25],0.468966038199937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19666,129,1.10 [0.94-1.30],0.2459817125525938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,19727,130,1.09 [0.76-1.57],0.6458403548206535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19662,131,1.08 [0.78-1.50],0.6336828032942031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,19220,129,1.21 [1.00-1.45],0.0471665484033624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,19662,131,1.31 [0.92-1.89],0.1376326809804636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22547,142,1.08 [0.92-1.26],0.3412376334288233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,22859,144,0.93 [0.57-1.51],0.7667251565645301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,22131,137,0.98 [0.64-1.52],0.9403530690196956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19767,131,0.96 [0.76-1.21],0.7168610198605915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19265,126,1.11 [0.93-1.32],0.2536662051585086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,19161,122,1.16 [0.89-1.50],0.270055747253129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,19226,124,0.88 [0.56-1.39],0.5808497330202544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,19159,128,0.96 [0.69-1.35],0.8256810498569743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,22898,144,1.56 [1.04-2.33],0.0300826846670717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22660,145,0.98 [0.84-1.15],0.7978597991280839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,19662,131,1.04 [0.70-1.54],0.8548317067659774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19161,122,1.29 [0.87-1.91],0.206867260196155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,19738,132,1.14 [0.93-1.41],0.2093654727357934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22289,137,1.08 [0.70-1.66],0.742955383459476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,19265,126,1.31 [0.73-2.35],0.3645670010389072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,19218,129,0.88 [0.58-1.32],0.5303064192791249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,19767,131,1.02 [0.85-1.22],0.8673446853421991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19666,129,1.26 [0.71-2.22],0.4314034110721314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,19389,130,1.32 [0.85-2.04],0.2130389074509584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22717,140,1.23 [0.76-2.01],0.397407090845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,19738,132,1.28 [0.83-1.99],0.2679263636860252
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,22672,144,1.12 [0.65-1.94],0.6823895636761921
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,22511,141,1.35 [0.81-2.25],0.2485717634248628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,19220,129,0.88 [0.64-1.21],0.4365979687836853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,22660,142,0.97 [0.84-1.11],0.6279878690296405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,22182,139,0.97 [0.67-1.40],0.8674257493149596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,19666,129,0.62 [0.35-1.12],0.1150819791121003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,22967,143,0.37 [0.15-0.89],0.0272338832684468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,22660,145,0.86 [0.64-1.16],0.3314759825218126
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,19767,131,1.00 [0.80-1.25],0.9944826043815967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,19265,126,1.07 [0.92-1.24],0.3958842866277425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19727,130,0.93 [0.68-1.29],0.6726895229006067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19598,129,0.96 [0.82-1.13],0.627213727450399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19161,122,0.87 [0.66-1.14],0.3026227393377471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19265,126,1.16 [0.78-1.72],0.4652298404173461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,22547,142,1.12 [0.87-1.45],0.371891106384873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,19218,129,1.13 [0.94-1.36],0.2009518315576644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22696,142,0.98 [0.78-1.24],0.8964353171272613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22946,144,1.03 [0.89-1.19],0.7099270746692612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19738,132,0.93 [0.72-1.20],0.5622580565079591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,19161,122,1.04 [0.71-1.51],0.8568749149024292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,22268,140,0.84 [0.49-1.44],0.5316452623231813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,19738,132,1.10 [0.90-1.33],0.3593347804107362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,19159,128,1.07 [0.88-1.29],0.4940286431223347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELN,Elastin,19767,131,1.12 [0.70-1.79],0.6345844550582092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,22592,141,0.91 [0.68-1.23],0.5562438056281269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,19161,122,1.16 [0.79-1.71],0.4404519674589761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22268,140,1.02 [0.75-1.40],0.8882499567504155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,18259,123,1.21 [0.86-1.69],0.2724924867425499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,22967,143,0.75 [0.31-1.79],0.5174075918227264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,22663,143,1.04 [0.86-1.26],0.6846748602655472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,22898,145,1.00 [0.80-1.25],0.9992771928860112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,19265,126,1.21 [0.91-1.60],0.1822512842683175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,19662,131,1.19 [0.97-1.47],0.1018436615402122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19161,122,1.33 [0.75-2.34],0.3295789803736586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,19161,122,1.21 [0.89-1.63],0.2203018981273213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22967,143,1.30 [0.79-2.14],0.2979572820125676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22801,144,1.14 [0.78-1.67],0.4853552710579043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19265,126,1.46 [0.92-2.33],0.1095874667229553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21997,139,0.93 [0.79-1.11],0.431449520397401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,19662,131,1.09 [0.80-1.49],0.5719550628672151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22182,139,1.09 [0.77-1.54],0.6339574344447183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22289,137,0.94 [0.45-1.94],0.8653704977955253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22289,137,0.92 [0.53-1.59],0.769633177355804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,19265,126,0.87 [0.63-1.20],0.4061893067338425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,19218,129,1.04 [0.61-1.77],0.8991319081009964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,19220,129,0.97 [0.74-1.28],0.8250880450423033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,22695,143,0.79 [0.68-0.92],0.0024134615167347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,19662,131,1.17 [0.88-1.57],0.2830697094347829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,22767,144,1.54 [0.99-2.38],0.0555237645399246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,22131,137,0.94 [0.73-1.20],0.6030913437958255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,21888,138,1.23 [0.75-2.01],0.4128855079070322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,19352,126,0.93 [0.51-1.72],0.8281103537548158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,22967,143,1.41 [0.78-2.56],0.2504658345093529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,22499,142,1.79 [1.12-2.88],0.0150615564878528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,22289,137,0.97 [0.76-1.24],0.8144552889819076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,19389,130,1.32 [0.98-1.77],0.0673379333672175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,22660,145,1.11 [0.93-1.34],0.2411492245139531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,19265,126,1.11 [0.89-1.39],0.3669957178317389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22864,144,0.93 [0.56-1.53],0.7688900426874624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,22768,145,1.48 [0.80-2.74],0.2141455614639544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,22631,143,0.94 [0.43-2.07],0.8754893660395644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,22768,145,1.75 [0.95-3.21],0.0729158650107922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,22592,141,1.06 [0.92-1.23],0.4127148284409488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,19220,129,0.99 [0.79-1.23],0.8956445349411273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,19071,126,1.24 [0.82-1.88],0.3003726689252433
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,22499,142,1.11 [0.92-1.32],0.27711840027892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,19389,130,0.90 [0.54-1.50],0.6963364229426794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,19218,129,0.84 [0.57-1.23],0.3608548634176208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19662,131,1.00 [0.65-1.54],0.9931467732753104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,19352,126,1.08 [0.94-1.26],0.2764136925680416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,22552,141,1.79 [1.01-3.17],0.0449530206030517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19161,122,1.13 [0.80-1.61],0.4817599577566654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,22967,143,1.19 [0.75-1.90],0.4647492168248344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,22692,144,1.19 [0.78-1.84],0.4195333637655712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,19071,126,1.20 [0.94-1.54],0.137833066760798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,19218,129,1.09 [0.83-1.43],0.5272743630772259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,19727,130,1.17 [0.96-1.42],0.1276595338522173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,19071,126,1.18 [0.82-1.68],0.3766593304400392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,19218,129,1.01 [0.83-1.22],0.9451826300478564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,19389,130,0.98 [0.60-1.62],0.9450485972538408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,19161,122,1.13 [0.88-1.46],0.3234888122046647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,19161,122,1.26 [0.93-1.70],0.1416487247363653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,22898,145,1.35 [0.73-2.47],0.339139010264273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,19769,129,0.73 [0.38-1.40],0.3419786973301271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,19501,123,0.87 [0.48-1.58],0.6461488344699233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,22706,144,1.08 [0.83-1.40],0.5671408663216739
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,19793,128,1.24 [0.83-1.87],0.294693284078508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,19675,127,0.59 [0.31-1.14],0.1149315360068422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,19793,128,2.18 [0.70-6.75],0.1759268903584069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,22762,144,1.08 [0.84-1.39],0.5597688388792128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,22761,142,0.75 [0.44-1.29],0.2995071664676515
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,22728,141,1.42 [0.85-2.36],0.1764198470316645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,22720,141,1.16 [0.50-2.65],0.7303260417505373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",22692,144,1.01 [0.86-1.18],0.9445234650291264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",22696,142,0.87 [0.72-1.07],0.1827654529926723
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",19767,131,0.92 [0.64-1.31],0.6282577384157666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",22967,143,0.99 [0.73-1.34],0.958360692679924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,22831,145,0.95 [0.77-1.18],0.6315188176336515
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,22256,137,0.83 [0.62-1.10],0.1990125447039091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,22660,145,1.27 [0.99-1.64],0.0607698331191141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,22696,142,1.08 [0.89-1.31],0.4312095165908205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,19666,129,1.06 [0.83-1.36],0.6472164598394701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,19738,132,1.09 [0.99-1.19],0.0843096245073127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,19662,131,1.09 [0.61-1.95],0.7791879511861881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,19265,126,1.16 [0.88-1.53],0.2836637015274947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,19767,131,1.51 [0.86-2.65],0.1538861368151037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,22592,141,0.82 [0.54-1.23],0.3315903712501348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,22662,142,1.19 [0.72-1.97],0.4951978708265746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,19666,129,0.91 [0.74-1.12],0.3820149377980187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,22967,143,0.68 [0.40-1.17],0.1678359465431613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,19220,129,1.01 [0.79-1.28],0.9628826625511104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,22898,142,0.88 [0.54-1.45],0.62238151210396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,22946,144,0.97 [0.65-1.44],0.8804201757173203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,19762,130,1.40 [0.83-2.37],0.210265016980498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,19220,129,1.15 [0.87-1.51],0.3367222121917393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",22696,142,0.98 [0.80-1.20],0.8257744130694673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19767,131,0.90 [0.71-1.14],0.3844796281611518
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,22660,145,1.03 [0.76-1.40],0.8579310475819159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19738,132,1.09 [0.55-2.15],0.8138065389073048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22706,144,1.30 [0.95-1.77],0.1008790293099446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22580,140,0.89 [0.72-1.12],0.3245241382839354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22182,139,0.99 [0.77-1.29],0.960970618966458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22689,141,0.92 [0.69-1.24],0.5955644708533571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,19728,129,1.18 [0.86-1.62],0.3138386140627992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,22568,141,0.91 [0.64-1.29],0.5864531753549316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,22696,142,1.07 [0.77-1.50],0.6787557178454029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,22839,144,0.93 [0.68-1.27],0.6553548429724757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,22268,140,0.71 [0.54-0.93],0.0138014383416224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,22706,144,0.93 [0.71-1.21],0.5916999559861632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,22660,145,0.95 [0.76-1.17],0.6160853260364139
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,22182,139,1.02 [0.79-1.32],0.8592857302453021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",19161,122,0.74 [0.54-1.03],0.0762085926797834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",19161,122,1.09 [0.82-1.45],0.5650330511096858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,22182,139,1.01 [0.80-1.27],0.961095621900826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,22182,139,1.06 [0.77-1.44],0.7361932278225937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,22720,141,1.06 [0.68-1.67],0.7875754375553776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,19319,122,0.69 [0.39-1.22],0.2006293147520707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19738,132,1.12 [0.91-1.38],0.2870630493418853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,19218,129,0.96 [0.66-1.41],0.8420862423543511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,19218,129,1.02 [0.72-1.44],0.9137606725205504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,22801,144,1.01 [0.83-1.22],0.9493282687048183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,22660,145,1.00 [0.80-1.24],0.990331822293268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,19218,129,0.84 [0.55-1.28],0.423712729348872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,22859,144,1.05 [0.93-1.19],0.4248605729706828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,22865,143,1.01 [0.78-1.30],0.9435416313817896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,19218,129,1.19 [0.74-1.91],0.474634849656014
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,22268,140,0.67 [0.41-1.08],0.0981147939018305
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,19218,129,0.78 [0.49-1.26],0.312339483723563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,19071,126,0.78 [0.60-1.03],0.0765997687466015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,19033,126,1.05 [0.69-1.59],0.8294231588468215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,22768,145,0.92 [0.58-1.46],0.7212268415505521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,19762,130,0.81 [0.58-1.14],0.2258910718909062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,19727,130,1.17 [0.74-1.84],0.5050536865178941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,22768,145,2.33 [1.22-4.46],0.0106522703785868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,19352,126,0.97 [0.71-1.33],0.8599860863131985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,19769,129,0.94 [0.73-1.22],0.6506044706609686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,22131,137,0.92 [0.70-1.22],0.5760956709418054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",19159,128,1.12 [0.94-1.34],0.1898949672715293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19161,122,1.12 [0.81-1.55],0.5052051364494341
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,22131,137,1.07 [0.87-1.31],0.541489862713206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,22698,143,1.01 [0.83-1.22],0.9517660425202038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19738,132,1.08 [0.91-1.27],0.3927667261588838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22764,143,1.06 [0.93-1.21],0.4082355126433286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22547,142,1.17 [0.84-1.64],0.3465581100883218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22547,142,1.07 [0.91-1.25],0.3944536920735099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22083,137,1.16 [0.86-1.56],0.333422559590682
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,19666,129,1.05 [0.79-1.40],0.7269523303639621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,22182,139,1.05 [0.91-1.20],0.5101941305338575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22547,142,1.27 [0.75-2.14],0.3708025720553594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,22552,141,1.19 [0.62-2.32],0.5991671385149646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,22182,139,0.53 [0.31-0.90],0.0197625752436197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,22946,144,0.92 [0.58-1.45],0.7179048169848097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,22768,145,0.73 [0.47-1.11],0.1417720058658214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,22131,137,0.95 [0.74-1.22],0.7022660459079009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,22182,139,1.00 [0.65-1.55],0.9834490993310488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,19793,128,1.23 [0.65-2.33],0.5179716729563982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,19727,130,1.28 [0.88-1.85],0.1921150188460379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19662,131,1.28 [0.83-1.97],0.2554307353594499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,19218,129,0.90 [0.74-1.09],0.2869429859258716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,22661,145,2.55 [1.58-4.10],0.0001246285443636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,22898,145,1.88 [1.16-3.05],0.01015585458512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,22694,144,0.95 [0.87-1.04],0.2411282483580505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,19033,126,1.02 [0.63-1.65],0.9473938541059592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,22131,137,1.16 [0.83-1.62],0.3954898344132174
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,19218,129,1.06 [0.73-1.53],0.7755058843193979
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,22660,145,0.97 [0.81-1.16],0.7349569582094848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,22182,139,1.05 [0.90-1.22],0.5650682678194947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,19161,122,1.01 [0.79-1.29],0.93025007813493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,19220,129,1.03 [0.63-1.69],0.897298009692993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,22471,141,1.13 [0.64-2.01],0.6708140807556426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19265,126,0.91 [0.71-1.17],0.4570357522493286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FST,Follistatin,22762,144,1.09 [0.82-1.45],0.550423136868798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,19265,126,1.39 [0.67-2.90],0.3766296685936515
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,22658,143,1.21 [0.76-1.95],0.4227866556930544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,19699,130,1.07 [0.88-1.30],0.5123317629111881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,22840,143,0.85 [0.72-1.00],0.0502776214866461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,19352,126,0.90 [0.69-1.19],0.4596672434125052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FURIN,Furin,22768,145,1.48 [0.96-2.29],0.0748123976367119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,22150,138,0.97 [0.66-1.43],0.8921940307806795
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19346,130,0.96 [0.73-1.25],0.7477097903439045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22898,145,0.90 [0.66-1.24],0.5326409194910436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",22547,142,1.10 [0.86-1.41],0.4604495532942205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",22898,144,1.11 [0.91-1.35],0.3048196718130166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,22268,140,1.02 [0.81-1.28],0.8953787155032064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,22671,144,1.00 [0.85-1.17],0.9857077618262098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,19220,129,1.33 [1.09-1.61],0.005135294179354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,19159,128,0.92 [0.61-1.39],0.6823239821629332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19662,131,1.24 [0.93-1.65],0.1399672241819267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19389,130,1.17 [0.95-1.45],0.1430223540327679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19159,128,1.00 [0.77-1.31],0.9868460613604184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,19071,126,1.19 [0.62-2.28],0.6085198266961771
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,19218,129,0.64 [0.41-1.03],0.0638388175922528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19389,130,0.82 [0.54-1.23],0.3271355758600797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19265,126,1.18 [0.86-1.61],0.2992199624718727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,19071,126,0.92 [0.69-1.23],0.5873633981744915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,22801,144,1.07 [0.85-1.36],0.5487412866598627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22592,141,1.22 [0.71-2.08],0.4685583298485499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22898,144,1.18 [0.67-2.07],0.5761066786182032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22268,140,0.98 [0.68-1.40],0.9147083883838492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19767,131,2.10 [1.25-3.52],0.0050707710105486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,22592,141,1.45 [0.71-2.96],0.3132684298961416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,19161,122,0.98 [0.62-1.54],0.9286574153926556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18929,124,1.41 [0.81-2.46],0.2266559376299512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,19738,132,0.96 [0.51-1.80],0.902910821631168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,19389,130,1.03 [0.75-1.41],0.861135216796994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,22819,142,1.08 [0.61-1.94],0.7851224115449541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,19161,122,1.35 [0.91-2.00],0.1351353288494193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,19727,130,1.11 [1.00-1.25],0.0602067785174505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19071,126,1.48 [0.80-2.74],0.2094354215886941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19265,126,1.10 [0.88-1.36],0.3990619624391596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,19220,129,0.96 [0.70-1.32],0.808542121586004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,19690,130,0.95 [0.73-1.22],0.6674107474677056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,22268,140,1.08 [0.85-1.39],0.5257424490000141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,22131,137,0.81 [0.59-1.12],0.209560513834638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,19161,122,0.80 [0.51-1.24],0.3123977334312064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,19793,128,0.93 [0.49-1.78],0.8267259910720649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,19727,130,1.07 [0.92-1.25],0.3892243385482513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,22182,139,1.11 [0.99-1.25],0.084327819496909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18882,123,1.07 [0.77-1.49],0.6822082670800592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,19161,122,0.77 [0.51-1.18],0.2313729693488676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22592,141,0.93 [0.61-1.44],0.753906526711621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,22967,143,1.31 [0.96-1.80],0.0849371542735243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,22696,142,1.63 [1.08-2.44],0.0188367690661581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,22131,137,1.21 [0.82-1.78],0.3384202834116087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,19767,131,0.95 [0.70-1.28],0.7254464260832956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,22146,139,0.90 [0.65-1.24],0.5033541451250098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,22182,139,0.99 [0.78-1.25],0.903042449447008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22182,139,0.99 [0.88-1.12],0.8484458202483195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,22859,144,1.19 [0.70-2.01],0.5253839026222327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,22592,141,1.51 [0.77-2.99],0.2337143293808338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,22480,141,1.45 [0.87-2.42],0.1541757973332842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,19136,128,0.97 [0.73-1.28],0.8238586451902832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,22131,137,1.24 [1.03-1.48],0.0216743957055951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,19767,131,1.10 [0.87-1.39],0.4311369709127727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,19724,131,1.07 [0.76-1.51],0.6822675350092096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22291,137,0.94 [0.60-1.46],0.7806108771934381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,22672,144,1.04 [0.77-1.40],0.8120709710427261
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,22547,142,1.04 [0.54-2.01],0.9052834273779536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,22662,142,1.01 [0.92-1.10],0.8987552508534506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,22182,139,0.89 [0.80-0.99],0.0288554084687024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,19352,126,0.99 [0.54-1.80],0.9663933505428288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,22131,137,1.07 [0.84-1.37],0.5727647944415124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,22696,142,1.04 [0.86-1.25],0.7084958018289864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,19738,132,1.20 [0.77-1.86],0.4245891067562382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,19738,132,1.06 [0.85-1.32],0.5958251658826884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,19352,126,0.69 [0.39-1.22],0.2015646196453713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,19071,126,0.86 [0.61-1.23],0.4143789209285246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,19265,126,0.92 [0.67-1.26],0.6104083206901837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,19727,130,0.83 [0.46-1.49],0.5315236020439358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,19666,129,1.05 [0.88-1.25],0.6102414375295371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,19218,129,0.63 [0.40-0.97],0.0375678521201661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,19218,129,1.04 [0.87-1.24],0.6831779549167948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,19071,126,0.93 [0.70-1.24],0.6320573912078054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,21702,133,1.38 [0.79-2.38],0.2543044140996352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,19309,126,1.20 [0.76-1.90],0.4330454378838703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,22547,142,1.26 [0.88-1.81],0.1987746103146901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,19218,129,1.07 [0.65-1.77],0.7954487384924154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,22289,137,0.98 [0.76-1.27],0.9055349787158646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,22659,143,0.85 [0.56-1.28],0.4276523850938561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,19159,128,1.14 [0.76-1.72],0.5176249227936398
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,22546,142,0.81 [0.62-1.06],0.1218195202767547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19352,126,1.12 [0.93-1.35],0.2387651968957962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22131,137,0.90 [0.64-1.27],0.5447198850436705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,19662,131,1.46 [1.21-1.76],6.421295105978911e-05
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,19285,127,0.98 [0.63-1.53],0.9431388068935146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,19767,131,1.11 [0.88-1.41],0.3667951070844589
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,22946,144,1.11 [0.83-1.49],0.4656051275497517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,19352,126,1.16 [0.90-1.49],0.2468000723524755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,19738,132,0.88 [0.72-1.08],0.2251989540292836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22182,139,1.05 [0.83-1.32],0.6811614004486062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19220,129,1.15 [0.88-1.50],0.3126396585326516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,22706,144,0.78 [0.59-1.04],0.0890474585888194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,19265,126,0.96 [0.56-1.62],0.8678808524109118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,19352,126,0.98 [0.61-1.57],0.9259567881357796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,19738,132,1.29 [1.06-1.57],0.0123074511478848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,22898,145,1.86 [1.02-3.39],0.0434275010411773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22660,145,0.99 [0.86-1.15],0.9161212405934736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,19666,129,1.11 [0.78-1.58],0.5717247447999299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",19762,130,0.95 [0.63-1.45],0.8274686030282169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,22567,140,1.10 [0.69-1.76],0.6773506639505713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,19161,122,0.92 [0.71-1.20],0.5549842918141917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22012,134,1.15 [0.98-1.36],0.0930774654379071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,19352,126,1.00 [0.62-1.61],0.9935956187735796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,22671,144,0.99 [0.84-1.17],0.9140393579256276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,22592,141,0.86 [0.77-0.95],0.0044621706367158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,22898,144,1.04 [0.63-1.71],0.8890745047345301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,22547,142,0.87 [0.67-1.13],0.3019478152968645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,19662,131,1.14 [0.83-1.56],0.4330467219964015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,19666,129,0.95 [0.66-1.36],0.7824121727125164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,19769,129,1.22 [0.87-1.72],0.2494377518269692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19666,129,1.25 [0.97-1.62],0.0910132083901282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,22131,137,0.95 [0.55-1.66],0.8689223945188023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,22081,140,0.84 [0.49-1.43],0.5188442859222755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,19159,128,1.13 [0.89-1.43],0.3231822801947747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,19738,132,1.24 [0.83-1.85],0.2965652048666861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,19666,129,0.78 [0.59-1.03],0.0836531459796806
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,22289,137,1.26 [1.01-1.59],0.0444562613159393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,19662,131,1.30 [1.02-1.66],0.0373375711036112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,22696,142,1.03 [0.91-1.16],0.6347330362432289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19767,131,1.09 [0.85-1.42],0.4926326206396746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",19738,132,0.96 [0.65-1.43],0.8386540971395529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19159,128,1.04 [0.78-1.38],0.7875613208108502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,22289,137,0.88 [0.64-1.22],0.4518179899366661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,22609,144,0.81 [0.43-1.51],0.5088376498152265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,19265,126,1.22 [0.89-1.66],0.2214105169195922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",22592,141,1.27 [1.01-1.60],0.0395085813666145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,18965,126,1.19 [0.98-1.46],0.0836777426107392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,22182,139,1.05 [0.89-1.23],0.5846189168955456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,19699,128,2.02 [0.86-4.78],0.108089624285237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",19649,128,0.80 [0.38-1.69],0.5591509344384283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,22661,142,0.99 [0.83-1.18],0.8987379385225018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,22182,139,0.89 [0.72-1.10],0.27241631234411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,19161,122,0.96 [0.75-1.23],0.73265363298257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,21994,136,1.18 [0.96-1.45],0.1098280129387259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,19727,130,1.02 [0.95-1.10],0.5613390786910811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19389,130,0.81 [0.60-1.09],0.1586842195397781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,19220,129,1.04 [0.84-1.28],0.7282318803845869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,22596,143,1.02 [0.65-1.59],0.943822485016678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,19389,130,0.95 [0.77-1.17],0.6071267634890862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,19161,122,1.22 [0.84-1.79],0.3011591185745137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,22804,142,1.02 [0.79-1.30],0.8880687523976077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",22289,137,1.09 [0.93-1.28],0.2967294967446692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,22946,144,0.84 [0.55-1.29],0.423123273067485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,22660,145,1.04 [0.84-1.30],0.7099731163468863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,22289,137,0.91 [0.74-1.13],0.3985965247116455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,19071,126,1.33 [1.06-1.67],0.0140677319039294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19161,122,0.81 [0.58-1.12],0.2008482658972573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22826,144,0.95 [0.78-1.15],0.5753463648661875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,22898,144,1.02 [0.91-1.14],0.766583733369368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",22706,144,1.04 [0.86-1.26],0.6591390478418232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,22865,144,1.11 [0.87-1.41],0.4026786465011862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,22706,144,1.31 [0.86-2.00],0.2009218246719643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,22826,144,0.99 [0.81-1.21],0.9402737972791716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,22898,144,0.86 [0.67-1.10],0.2184185411098982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,19767,131,0.95 [0.81-1.12],0.5680455531171928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,19161,122,1.17 [0.93-1.48],0.1817687397726511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,22946,144,1.04 [0.80-1.36],0.7758360062176448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,19218,129,0.89 [0.65-1.22],0.4601675120073201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,19159,128,0.83 [0.60-1.13],0.2366108578130886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,19666,129,0.80 [0.54-1.18],0.2546638644092369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,22869,144,1.07 [0.92-1.24],0.4058161056704594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,19727,130,1.09 [0.84-1.41],0.5076553960952612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,22289,137,0.84 [0.62-1.13],0.2544404928355878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19352,126,0.67 [0.35-1.28],0.2234085925209203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,19727,130,1.00 [0.67-1.52],0.9836632475565684
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,19767,131,1.07 [0.55-2.09],0.8325942280263587
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,22660,145,1.01 [0.84-1.21],0.8952205866908705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,22946,144,1.30 [0.85-1.98],0.2277953517578139
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,19573,126,1.01 [0.56-1.81],0.981639329342633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22182,139,1.02 [0.84-1.23],0.8566411220529153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,19727,130,1.14 [0.91-1.42],0.2533071215834339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,19218,129,1.04 [0.82-1.32],0.7597515822628569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,19161,122,0.85 [0.49-1.48],0.5598244441218666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,19692,130,1.05 [0.71-1.53],0.8217617655312623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,19738,132,1.16 [0.83-1.62],0.3810479833930354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,22289,137,0.94 [0.55-1.62],0.8353896268467046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19738,132,1.12 [0.67-1.87],0.6589037082465857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22594,145,0.91 [0.61-1.37],0.6669216429352898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22660,145,0.97 [0.58-1.63],0.9045340962469602
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,22898,144,0.77 [0.56-1.06],0.1058144069024809
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,19315,125,0.90 [0.67-1.21],0.4855354857355064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19265,126,1.12 [0.81-1.57],0.4894989840311932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19161,122,1.19 [0.83-1.70],0.3516279243970591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,19043,126,0.96 [0.67-1.37],0.8225927284278897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22446,141,0.85 [0.61-1.18],0.3227010938643336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,22131,137,1.11 [0.81-1.52],0.5146895877400735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,19220,129,1.07 [0.86-1.33],0.5458902479297334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,22428,141,0.90 [0.65-1.24],0.5003473282376976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22224,137,1.02 [0.84-1.24],0.8519206578803732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19738,132,1.04 [0.74-1.46],0.8292157242159446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,22946,144,1.07 [0.87-1.31],0.5270623857128589
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,22182,139,0.92 [0.61-1.38],0.6719871040525046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,19482,127,0.99 [0.82-1.19],0.8988858810600981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,19353,130,0.93 [0.77-1.13],0.4708950080945748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19265,126,1.04 [0.65-1.65],0.8772228480487798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,19675,127,0.65 [0.38-1.11],0.1131676005231634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,19265,126,1.06 [0.87-1.28],0.5767685935956031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22592,141,1.05 [0.71-1.55],0.8192934104847478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22898,144,1.00 [0.65-1.53],0.9834467736057962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19218,129,1.37 [0.80-2.34],0.2472598705392318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,19265,126,1.08 [0.90-1.29],0.3954744568792818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22660,145,1.04 [0.72-1.52],0.8237243733156343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19727,130,0.86 [0.66-1.13],0.277969005677991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19161,122,1.15 [0.83-1.60],0.3949546072656603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19265,126,1.35 [0.96-1.89],0.0833378077528371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,22029,137,0.90 [0.70-1.16],0.4095597285861693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,22767,144,1.07 [0.87-1.31],0.5118990506315315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,19662,131,0.81 [0.47-1.38],0.4389894057528059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,22327,139,0.95 [0.76-1.19],0.6694533215105251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,22898,144,1.03 [0.68-1.55],0.8979316683364388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22499,140,1.33 [0.75-2.39],0.3304420673750732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,19159,128,0.96 [0.77-1.19],0.7206492307422006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,19159,128,0.77 [0.50-1.21],0.2617375497657943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",22768,145,1.06 [0.84-1.34],0.6320125405901431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,22528,139,0.77 [0.40-1.50],0.4480859659337824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,22967,143,1.30 [0.66-2.57],0.4432707303318306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,22268,140,1.02 [0.84-1.24],0.8284847138146944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,22578,140,0.84 [0.49-1.43],0.5106477422403632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,22967,143,0.50 [0.32-0.79],0.0031151526053513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,22967,143,0.73 [0.40-1.32],0.2942672161715294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,22660,145,1.17 [0.88-1.54],0.2862288301455641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,22696,142,1.01 [0.72-1.41],0.9705868517410297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,22592,141,1.05 [0.48-2.28],0.905652033554573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,19389,130,0.88 [0.58-1.32],0.5303294992322531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22131,137,1.10 [0.80-1.51],0.5659049461193648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",19265,126,0.79 [0.60-1.04],0.0928662588145383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,22946,144,1.42 [0.24-8.24],0.6979494808073803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,22898,144,1.05 [0.76-1.45],0.753645166641209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19180,124,1.14 [0.74-1.77],0.5562647456510008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19389,130,1.05 [0.77-1.43],0.7700247931582107
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19389,130,0.99 [0.63-1.54],0.9587762831816556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,19666,129,0.96 [0.50-1.83],0.9001685269333128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,22268,140,0.91 [0.80-1.03],0.1355104091914345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,22801,144,1.64 [0.80-3.36],0.1752657997521403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,22547,142,1.30 [0.99-1.70],0.0615196821303317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,22131,137,1.24 [0.90-1.71],0.1905099051075127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,19159,128,1.07 [0.84-1.36],0.597894652340212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,22660,145,0.86 [0.56-1.31],0.4782901119132955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,19161,122,0.97 [0.60-1.57],0.9084090104453734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,19220,129,1.21 [0.84-1.75],0.2986089501391776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,19738,132,1.12 [0.86-1.47],0.3945005879240973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19159,128,0.82 [0.55-1.24],0.3545717416820663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19762,130,1.24 [0.64-2.38],0.5235501989075233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,22592,141,1.13 [0.58-2.19],0.7171549004298773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19161,122,1.25 [0.92-1.71],0.1478981204698383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,22706,144,1.12 [0.58-2.14],0.7390073930393893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,22928,143,1.02 [0.90-1.16],0.7144818696469724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,22928,143,0.99 [0.79-1.26],0.9600301304477326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,22757,141,0.94 [0.55-1.61],0.8197440911246916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22408,141,1.22 [0.86-1.74],0.2652065728057323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,22574,140,1.30 [0.78-2.18],0.3162667897820362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,22967,143,1.08 [0.65-1.79],0.7725797366002827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22696,142,1.44 [0.94-2.20],0.0907504996145007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,19218,129,0.95 [0.75-1.21],0.6810194142475503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,19161,122,1.10 [0.82-1.49],0.512836930550628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,19754,128,0.60 [0.25-1.42],0.2413174543807767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,19071,126,1.00 [0.83-1.20],0.9909770175430278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,19265,126,1.11 [0.73-1.68],0.6349303399286834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,22592,141,1.04 [0.66-1.64],0.85141039022576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,22696,142,1.39 [0.86-2.27],0.1822614342630028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,19767,131,1.21 [0.99-1.48],0.0574663880346048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,22660,145,0.96 [0.81-1.13],0.5935858023202847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,22182,139,0.92 [0.77-1.11],0.4017790817325591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,22268,140,1.10 [0.93-1.30],0.2560744442647993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,22268,140,1.04 [0.82-1.32],0.7298167568593446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,22801,144,1.79 [1.14-2.82],0.0118672800253704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,22268,140,1.10 [0.90-1.36],0.3483173433958147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,22592,141,0.92 [0.76-1.12],0.3944775761908775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,22946,144,0.93 [0.71-1.21],0.576203011583351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,22268,140,1.25 [0.84-1.85],0.2654280883465695
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,19218,129,1.15 [0.78-1.71],0.4765705584806556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,22268,140,1.09 [0.83-1.43],0.5535940071805454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22412,143,1.40 [0.68-2.86],0.3620389798585666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,19159,128,1.36 [0.76-2.42],0.2968368638213357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,22660,145,1.10 [0.71-1.73],0.6632900465016331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,22268,140,1.37 [0.89-2.10],0.1489257212356658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,22946,144,0.99 [0.70-1.41],0.9612312052747072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,22244,140,0.97 [0.68-1.37],0.8452257816722382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,22268,140,1.07 [0.87-1.31],0.5100203022902583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,22268,140,0.80 [0.49-1.33],0.3988056991373333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,22268,140,1.00 [0.83-1.21],0.9982787726971156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,22706,144,1.09 [0.78-1.53],0.5953726751726283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22367,145,0.92 [0.70-1.22],0.5817161542894875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,22617,144,0.93 [0.68-1.27],0.6292375875190901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,22757,141,1.45 [0.91-2.30],0.1208434541014885
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,22946,144,1.29 [0.83-1.99],0.2572623669606826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,22400,141,1.01 [0.92-1.09],0.9069589810964944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22128,138,1.12 [0.90-1.39],0.3132639260289452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,22268,140,1.06 [0.83-1.37],0.6329191312237693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,22166,139,1.01 [0.78-1.32],0.9307856389502585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,22672,144,1.48 [0.77-2.85],0.2400975253285907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,22663,144,1.12 [0.52-2.40],0.7695974732699595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,22706,144,0.84 [0.60-1.19],0.332364825432514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,22898,142,1.35 [0.97-1.88],0.077218329847742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,22268,140,0.98 [0.67-1.43],0.9151978866220458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,22657,143,0.83 [0.62-1.10],0.2019891413708621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,22268,140,1.67 [1.03-2.73],0.0381459110125914
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,22268,140,1.00 [0.75-1.33],0.9815246809690464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,22268,140,1.16 [0.87-1.54],0.3164180794989677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,19218,129,0.69 [0.45-1.06],0.0923133364271442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,19218,129,1.11 [0.84-1.46],0.4622549620382234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,19662,131,0.97 [0.75-1.25],0.8052143044826388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,22268,140,1.17 [0.86-1.58],0.3219902488895318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,22268,140,0.99 [0.72-1.34],0.9256285675468728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,19001,126,0.79 [0.48-1.30],0.354413976835041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,22522,138,1.28 [0.89-1.85],0.1851873974932235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,22268,140,0.94 [0.63-1.40],0.7563773516651807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,19662,131,0.88 [0.55-1.41],0.599516237424317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,19071,126,1.16 [0.86-1.57],0.3215125278125765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,19218,129,1.13 [0.87-1.47],0.3729651164910479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,19143,129,0.96 [0.63-1.46],0.8345521287829979
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,22660,145,0.69 [0.48-1.00],0.0497484429379048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,22268,140,1.17 [0.79-1.72],0.4269552225571513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,22101,137,1.41 [0.92-2.18],0.1176146036161669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,19218,129,1.01 [0.76-1.35],0.9315648425727546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,19136,129,0.83 [0.62-1.10],0.1857947314117929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,22268,140,1.01 [0.63-1.61],0.9712108445105864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,22268,140,0.93 [0.80-1.08],0.3345463118934529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,22660,145,1.02 [0.67-1.54],0.9350713271611836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,22268,140,1.00 [0.90-1.11],0.99485111375574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,22660,145,1.04 [0.79-1.36],0.7781540307378879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,22592,141,1.05 [0.87-1.27],0.6109489991924397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,22534,140,1.52 [0.98-2.36],0.0628111731678273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,22696,142,0.54 [0.23-1.30],0.1691031983390199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,22660,145,0.93 [0.74-1.16],0.5110203016187478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,22706,144,1.06 [0.80-1.41],0.6626331588742167
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,19389,130,1.00 [0.74-1.34],0.9888895902050584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22106,137,0.92 [0.70-1.21],0.5358097565412973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,19662,131,1.14 [0.79-1.62],0.4858978097518708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,22547,142,1.06 [0.83-1.35],0.647188651884929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,19727,130,1.06 [0.79-1.42],0.705581737259053
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,19159,128,1.04 [0.59-1.83],0.8846901397130968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,22083,137,0.72 [0.50-1.05],0.0868731607492236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,19352,126,1.20 [0.87-1.65],0.2711545501994311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,22706,144,1.01 [0.71-1.42],0.9666736638030292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,22592,141,1.07 [0.81-1.40],0.6499063047876299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19265,126,1.02 [0.75-1.38],0.8991625558245664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19738,132,1.18 [0.84-1.65],0.3394855816961606
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22592,141,0.99 [0.85-1.15],0.8910486645736968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,19727,130,0.87 [0.67-1.13],0.2883921199046676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,19662,131,0.90 [0.63-1.29],0.5742056564486577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,19666,129,1.06 [0.89-1.27],0.5068482849697157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,19218,129,0.75 [0.27-2.06],0.5707466315195517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,22511,141,1.06 [0.89-1.25],0.5324626088638136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22592,141,0.90 [0.69-1.19],0.4708462198462586
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22289,137,0.87 [0.73-1.05],0.1427874463052967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,22268,140,1.00 [0.80-1.25],0.9886733310217792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,22660,145,1.00 [0.87-1.15],0.9954461353615884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21822,136,0.86 [0.57-1.30],0.4647327624918468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,22660,145,1.37 [0.94-2.00],0.1052102867747399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,19762,130,0.91 [0.61-1.35],0.6282166940230562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,19526,129,1.08 [0.91-1.28],0.3953687987135799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,22660,145,0.74 [0.48-1.13],0.1634229233934147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,19352,126,0.70 [0.42-1.16],0.1681875187812743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,22706,144,1.05 [0.58-1.91],0.8623252205534913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,22660,145,1.17 [0.91-1.52],0.2202105298320939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,19218,129,1.23 [0.82-1.85],0.3070682387504224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,22706,144,0.68 [0.42-1.09],0.1110032660962735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,22898,144,0.75 [0.30-1.85],0.5289688034340672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,19389,130,1.04 [0.77-1.41],0.8046254980346164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,22648,140,1.01 [0.50-2.01],0.986092273139291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,22182,139,0.92 [0.64-1.32],0.6488231630915128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,22289,137,1.02 [0.89-1.17],0.7791274952529595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,22546,140,0.70 [0.41-1.19],0.1835214558400408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,22768,145,1.04 [0.70-1.54],0.8486024346809953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,22268,140,1.15 [0.69-1.91],0.5879966186063251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,22898,144,1.21 [0.89-1.65],0.227983876895706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,19762,130,0.95 [0.58-1.55],0.8376811247164201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19793,128,1.21 [0.51-2.89],0.6604681048795977
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22757,141,1.66 [1.10-2.50],0.0157036208295285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19793,128,1.34 [0.74-2.42],0.3363380175226543
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19662,131,1.00 [0.69-1.44],0.98216429687969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,22660,145,1.06 [0.83-1.36],0.6474174121883405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,19161,122,1.05 [0.81-1.35],0.7232445724303935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19265,126,0.93 [0.72-1.20],0.582267659513207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19159,128,1.50 [1.14-1.98],0.0043368509410582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22131,137,1.00 [0.74-1.36],0.984537064445704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,19071,126,0.69 [0.44-1.09],0.1132852972013323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,22898,145,1.59 [0.92-2.76],0.098077430051727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,19352,126,1.24 [0.90-1.71],0.1930287408288634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22268,140,0.86 [0.67-1.10],0.2285019484670004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19071,126,1.15 [0.88-1.51],0.3086834787683888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,19666,129,1.06 [0.87-1.29],0.5603155083867593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,22268,140,0.80 [0.57-1.14],0.2210218539513329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22592,141,1.02 [0.73-1.42],0.9112322708534726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,19666,129,1.01 [0.86-1.19],0.8695779708177581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,19159,128,1.02 [0.75-1.37],0.9155954866415558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,19220,129,0.86 [0.67-1.12],0.2613275651044657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,22131,137,0.93 [0.68-1.29],0.6723351867868721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,19364,129,1.28 [0.91-1.81],0.1626886126045481
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,19218,129,0.83 [0.65-1.05],0.1265303152861761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,22768,145,0.80 [0.45-1.42],0.4376506000208212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,22131,137,0.79 [0.52-1.21],0.2722856040310388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,19071,126,0.86 [0.64-1.15],0.296742131074015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,19265,126,1.10 [0.84-1.44],0.4970065032861255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,19727,130,0.75 [0.42-1.33],0.3181242765934267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,19389,130,0.92 [0.73-1.17],0.5131544024871668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,19389,130,1.46 [0.87-2.46],0.1531927976900753
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,19662,131,0.90 [0.65-1.24],0.5146484901292238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,19161,122,0.88 [0.52-1.49],0.6234652830313476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,19159,128,0.81 [0.64-1.04],0.0941768736119623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,19161,122,1.07 [0.93-1.24],0.3324788629458057
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,22592,141,1.02 [0.85-1.23],0.8017698508180873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19662,131,0.86 [0.71-1.05],0.1390517906275054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22182,139,0.88 [0.72-1.07],0.2117422353600008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19666,129,0.93 [0.84-1.03],0.1446069108768766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22182,139,1.05 [0.93-1.19],0.4279230179565622
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19071,126,1.10 [0.92-1.31],0.2986741164866121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,19159,128,0.83 [0.58-1.17],0.2763003475199369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,22131,137,1.31 [0.91-1.89],0.1490781538954931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,22720,141,0.63 [0.38-1.03],0.0640145965482878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,22696,142,1.14 [0.75-1.73],0.5389301555055077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,22131,137,0.93 [0.75-1.14],0.4669569004316308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,19159,128,0.66 [0.41-1.04],0.0737630401016322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,19738,132,1.21 [0.88-1.65],0.2443166158268908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,22460,145,1.11 [1.00-1.24],0.0598655943307634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,22696,145,1.08 [0.75-1.55],0.6877852876133368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,22544,144,1.44 [0.94-2.20],0.092773952735728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,22182,139,1.00 [0.90-1.11],0.92656418957187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,22192,138,0.78 [0.55-1.09],0.1452382197289256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,22898,144,1.23 [0.90-1.68],0.1993360481025734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,19637,131,1.26 [0.92-1.74],0.1556564387039177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,19762,130,0.85 [0.63-1.14],0.2656746593044081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,22898,144,1.06 [0.83-1.34],0.6469401132158317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,22740,144,1.16 [0.71-1.88],0.5571773565242948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,18831,125,0.91 [0.58-1.43],0.6792276124621576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,21936,140,1.03 [0.67-1.57],0.895276600835566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,19390,123,1.26 [0.64-2.50],0.5050525135827091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22946,144,1.11 [0.75-1.64],0.6161673430468453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19159,128,0.96 [0.71-1.29],0.7881452734182383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,22946,144,0.76 [0.55-1.05],0.1007438297826212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19218,129,1.08 [0.76-1.55],0.6686009849893294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,19727,130,0.91 [0.63-1.30],0.5870369728035334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",21406,135,0.55 [0.29-1.01],0.0531026650982724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",19161,122,0.93 [0.58-1.50],0.7665996149944355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",22592,141,1.04 [0.86-1.26],0.693069118248715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",22626,144,1.02 [0.82-1.27],0.865250121141667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",22131,137,1.07 [0.78-1.47],0.6577759684838173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",19161,122,1.23 [0.84-1.80],0.298167626620122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",19159,128,0.81 [0.58-1.12],0.1976205271004132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,22656,141,1.05 [0.81-1.36],0.7042611583864273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,22946,144,0.76 [0.54-1.05],0.0998350191678413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,22768,145,1.01 [0.60-1.70],0.9669521304670164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19767,131,1.09 [0.91-1.31],0.3597541373189973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,19625,131,1.11 [0.83-1.48],0.492667792066127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,22696,142,1.01 [0.81-1.26],0.9443351535481732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,22592,141,1.01 [0.70-1.47],0.9437921562470708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22692,144,1.30 [0.91-1.86],0.1501086212659095
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22547,142,1.04 [0.90-1.20],0.581637113739385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,19161,122,1.15 [0.88-1.51],0.3095690518064978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,22801,144,1.10 [0.71-1.72],0.673299299435325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19265,126,2.02 [1.13-3.63],0.0178056070560937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,19211,128,0.43 [0.19-0.98],0.0436904839653958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,22011,142,1.54 [0.68-3.49],0.3053603587768465
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22906,144,1.07 [0.81-1.42],0.6280318350469938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,19662,131,1.07 [0.72-1.57],0.7423812095856086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,22268,140,0.95 [0.70-1.31],0.7739716664340528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,19662,131,1.03 [0.80-1.34],0.7960286952401816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,22946,144,1.06 [0.87-1.29],0.5546596407211767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,22592,141,1.02 [0.90-1.15],0.7876888346259855
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,19218,129,1.11 [0.91-1.36],0.3035874130952412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,22499,142,1.42 [0.93-2.16],0.1083843696387823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,22757,141,1.03 [0.80-1.32],0.8376825538898985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,22898,145,0.98 [0.79-1.22],0.8668124012149899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,19769,129,0.95 [0.45-2.03],0.9024862360526482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,19738,132,0.93 [0.70-1.23],0.5946166812150835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,21986,135,1.13 [0.76-1.67],0.552640222566079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,19762,130,0.89 [0.62-1.28],0.5408749225514639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,22756,141,1.06 [0.80-1.41],0.6862857908682858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19738,132,1.10 [0.92-1.31],0.283812984223435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,19767,131,1.01 [0.78-1.30],0.941533562267326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,22859,144,1.18 [0.88-1.57],0.2694162534059969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,18691,124,0.93 [0.72-1.20],0.5909907190776262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,19159,128,0.86 [0.66-1.12],0.2612385355643954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,19738,132,1.34 [0.96-1.87],0.0890559122298005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEP,Leptin,22696,142,0.96 [0.76-1.21],0.734929731065447
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,22696,142,0.73 [0.44-1.22],0.2290226910435601
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,19738,132,1.28 [0.96-1.73],0.0978945338937487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,22696,142,1.31 [0.85-2.00],0.2222644430601713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,22749,142,1.46 [0.90-2.37],0.1243351966819949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,19793,128,1.50 [0.93-2.42],0.0928629668836321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,22692,144,0.94 [0.71-1.24],0.6411235942901073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,22661,144,1.04 [0.72-1.50],0.8540153456818811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,22898,145,1.05 [0.83-1.34],0.6889411559496827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,22693,143,0.89 [0.56-1.42],0.6289707917860126
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,22801,144,0.92 [0.61-1.39],0.6928999114060959
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,22182,139,0.87 [0.71-1.06],0.1635065902377817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22726,144,0.98 [0.77-1.26],0.895211236035032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,22131,137,0.93 [0.69-1.27],0.6573568191375575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,22660,145,0.83 [0.45-1.53],0.5463388576118029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22706,144,1.06 [0.70-1.60],0.785481586398012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19762,130,0.96 [0.86-1.08],0.5035419110032966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19161,122,1.10 [0.81-1.51],0.5342026119231627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22662,142,0.83 [0.52-1.33],0.4355253983035263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19767,131,0.87 [0.70-1.09],0.2298850251693945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22967,143,0.74 [0.43-1.27],0.2793821772732311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22859,142,1.08 [0.71-1.67],0.71057319842041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22268,140,1.17 [0.83-1.65],0.368113758770156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22967,143,0.95 [0.78-1.17],0.6473140198801767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,19265,126,1.11 [0.84-1.47],0.4501666464829176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,19623,129,1.16 [0.90-1.49],0.2570696590859616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,19727,130,1.65 [0.95-2.87],0.0783255153016505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,19738,132,0.98 [0.61-1.58],0.94574113253348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,19159,128,0.95 [0.72-1.25],0.7134361017582641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",19265,126,1.03 [0.85-1.26],0.7404079691762419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),19294,121,0.98 [0.89-1.08],0.7052332237737917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22592,141,0.91 [0.61-1.36],0.6572388616681222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,22696,142,1.02 [0.74-1.41],0.8949092875168666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,21993,138,0.96 [0.74-1.24],0.7537138255783237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,19161,122,1.05 [0.81-1.37],0.7080028450857054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19161,122,1.11 [0.86-1.42],0.4294650191506443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19220,129,1.02 [0.73-1.43],0.9097126002756156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,19793,128,0.66 [0.35-1.24],0.1966621003577752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22826,144,1.38 [0.90-2.12],0.1344306331435587
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19143,129,1.09 [0.62-1.92],0.7610031550678662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,22592,141,1.55 [0.90-2.67],0.1122749620804787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,22696,142,1.24 [0.82-1.88],0.3054772208992696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,19220,129,0.87 [0.54-1.40],0.5619915352858091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,19220,129,0.81 [0.63-1.04],0.0927427879553071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22898,145,1.23 [0.99-1.53],0.057553313816026
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,22592,141,1.31 [0.91-1.89],0.1480553413973971
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19666,129,0.91 [0.61-1.36],0.6453258173094871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,19220,129,0.97 [0.68-1.38],0.8772523876319758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,19767,131,1.28 [0.92-1.77],0.1367557663130738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19662,131,1.08 [0.76-1.51],0.678068348486119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,22268,140,1.02 [0.69-1.51],0.92559219011865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19220,129,1.14 [0.77-1.67],0.5205233050267701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19738,132,1.02 [0.55-1.89],0.950628239668807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,22182,139,1.07 [0.83-1.38],0.5797701963916455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19389,130,1.08 [0.91-1.28],0.3760979743459438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,22660,145,0.98 [0.68-1.42],0.9235802688710948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,22660,145,0.92 [0.64-1.33],0.6719698699119336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,22898,144,1.18 [0.92-1.51],0.1890282449079023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,19662,131,1.08 [0.69-1.70],0.7309299070817441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,22967,143,1.24 [0.78-1.97],0.3670292316920318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,22182,139,0.95 [0.71-1.28],0.7437786105789277
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,22589,143,1.27 [0.75-2.16],0.3740131850266839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,22268,140,1.10 [0.78-1.55],0.5840940020591138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,19662,131,1.16 [0.82-1.63],0.4076673900415674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LXN,Latexin,22444,142,1.00 [0.80-1.25],0.9712634976454888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,22588,141,0.87 [0.58-1.31],0.5075198365309282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,22660,145,0.95 [0.65-1.39],0.7946950532133636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,22478,142,0.74 [0.44-1.26],0.2697248330456494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,22547,142,1.20 [0.79-1.81],0.3844993206684171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,22182,139,1.02 [0.77-1.35],0.8986635444392557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,22592,141,1.11 [0.93-1.32],0.2630746368264046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,22131,137,0.96 [0.75-1.23],0.7467202913682147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,22580,144,0.86 [0.55-1.34],0.503967288808675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,22182,139,0.91 [0.67-1.24],0.5586714157581425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,19159,128,1.02 [0.88-1.19],0.79736357368001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19220,129,1.03 [0.88-1.21],0.7390842987972878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19793,128,1.46 [0.63-3.41],0.3805270711219778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,19071,126,1.36 [0.90-2.05],0.1437553362407142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,19352,126,1.09 [0.86-1.39],0.4700471694637734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,19265,126,0.75 [0.46-1.23],0.2571465031738904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22463,142,1.19 [0.91-1.54],0.2021588968800516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,22182,139,1.28 [0.93-1.77],0.1278212450286147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,19220,129,0.89 [0.62-1.27],0.5279973337737234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,19389,130,1.07 [0.87-1.31],0.5099630107229678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,22182,139,0.98 [0.71-1.34],0.8930907620606875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,19767,131,1.20 [0.75-1.94],0.4485765916162541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,19662,131,0.99 [0.73-1.35],0.9453673096806992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19265,126,1.02 [0.51-2.00],0.9644718285224856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,19767,131,1.01 [0.76-1.34],0.9500129410792436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19071,126,0.96 [0.68-1.36],0.8399831312336792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,22801,144,1.02 [0.90-1.16],0.7478061839359157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,22768,145,1.51 [0.89-2.56],0.1252858946542756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,19161,122,0.89 [0.68-1.16],0.3730202331381365
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19159,128,0.99 [0.58-1.69],0.9662148951148276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19161,122,0.98 [0.75-1.27],0.8540619211816017
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,19727,130,1.07 [0.75-1.54],0.7091989229485234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19666,129,1.09 [0.84-1.42],0.5191413256721423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22660,145,0.99 [0.85-1.14],0.8796166165964548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22182,139,1.00 [0.86-1.17],0.9904007930011164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22499,142,1.02 [0.89-1.17],0.7712563881441767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,19071,126,0.86 [0.57-1.30],0.4783763979202642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,22660,145,1.04 [0.74-1.47],0.8000921209489564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,19389,130,1.14 [0.91-1.43],0.2632880527907741
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,19071,126,0.95 [0.84-1.09],0.4802658879300071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,22131,137,0.89 [0.68-1.17],0.3912053883273572
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,22696,142,0.99 [0.56-1.73],0.95820689528521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",19309,126,1.01 [0.83-1.24],0.8888453642230781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,22499,142,1.37 [0.72-2.59],0.3405871291599195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,22734,144,1.39 [0.85-2.29],0.1900324350350665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,22511,141,1.06 [0.66-1.71],0.8041393616250716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,22182,139,0.98 [0.83-1.15],0.8001232868348105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAX,Protein max,22131,137,1.11 [0.96-1.29],0.1487184829462343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,22967,143,1.04 [0.77-1.40],0.8030542722579378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,19502,124,0.91 [0.78-1.07],0.2736528205354551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,22757,141,0.94 [0.61-1.46],0.7796842683247549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19738,132,1.24 [0.89-1.73],0.2010210170425111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,19218,129,1.15 [0.97-1.37],0.1175658902909159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,22599,142,1.05 [0.74-1.47],0.7982598263551387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,19666,129,0.98 [0.51-1.88],0.9486960798526736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22547,142,0.89 [0.72-1.10],0.2773557800181898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",19647,128,1.13 [0.76-1.70],0.5452155523951905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDK,Midkine,22709,145,1.01 [0.76-1.34],0.9440785445935128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,19220,129,1.25 [0.74-2.11],0.4094548501277419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19265,126,1.13 [0.94-1.36],0.1985697736309448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,22182,139,1.01 [0.83-1.24],0.8921549368173167
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,19161,122,0.90 [0.62-1.32],0.6005391406951056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,22692,144,1.17 [0.79-1.73],0.4267009657099954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,19161,122,0.98 [0.59-1.64],0.9531973501914248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,22898,142,1.06 [0.51-2.18],0.8804170203264264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,19767,131,1.12 [0.63-2.00],0.6900110524482945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,19352,126,1.00 [0.46-2.19],0.9964916347555742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,19666,129,0.89 [0.69-1.14],0.35793465146491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,22696,142,0.99 [0.87-1.12],0.8721817428909331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,22692,144,1.16 [0.66-2.04],0.5963410961999951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,22946,144,1.21 [0.69-2.13],0.5001504271234072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,22706,144,1.02 [0.91-1.16],0.7075717638782275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,22752,141,0.58 [0.28-1.21],0.1500177177803134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,22131,137,0.96 [0.57-1.60],0.8772836493141166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22660,145,1.06 [0.89-1.27],0.4939691400774996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,22859,144,1.08 [0.84-1.39],0.5595126365802923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,22289,137,1.00 [0.74-1.35],0.9943093872535648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,19220,129,0.92 [0.70-1.21],0.5512524929812028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19352,126,1.35 [0.78-2.32],0.278489477203564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,22967,143,1.02 [0.71-1.47],0.9191341121792715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,22706,144,0.90 [0.63-1.28],0.5477686586228383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,22762,144,0.97 [0.82-1.15],0.7640687591271571
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22660,145,1.02 [0.90-1.15],0.8001110675420535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,22768,145,1.08 [0.73-1.60],0.7120418007436357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,19220,129,1.06 [0.84-1.34],0.6444098109841784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22660,145,0.96 [0.88-1.05],0.3752208252023867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,22673,141,1.01 [0.81-1.25],0.9394058251420224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,22268,140,0.89 [0.66-1.21],0.4688577015249834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19662,131,1.03 [0.88-1.21],0.6878885223010696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,19727,130,1.08 [0.90-1.30],0.3840887694215603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,22547,142,1.00 [0.86-1.17],0.959103816713478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,19218,129,1.10 [0.74-1.63],0.6400924057437662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,19071,126,0.84 [0.64-1.11],0.2291574434270625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,22660,145,1.05 [0.89-1.23],0.5894000260151746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,22592,141,1.02 [0.86-1.22],0.8014285263587287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,21826,137,0.98 [0.83-1.15],0.7947521343415236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,22661,144,1.16 [0.92-1.48],0.2126536636002149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22718,144,1.22 [0.92-1.61],0.1704985719838467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22131,137,1.23 [0.77-1.95],0.3874145219658302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,19767,131,1.04 [0.76-1.42],0.7948608779884997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,22706,144,1.25 [0.94-1.68],0.1306346502410876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,22248,137,0.91 [0.66-1.25],0.545456810105311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,22858,145,1.11 [0.92-1.36],0.2749923059461009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,22665,144,1.15 [0.90-1.46],0.262981942159486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19161,122,1.10 [0.78-1.55],0.5945777764546988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,19220,129,1.17 [0.91-1.50],0.2118961579976106
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,19389,130,1.21 [0.86-1.70],0.2662408008648891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,22661,142,0.94 [0.81-1.10],0.4549449247122034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,19352,126,0.93 [0.72-1.21],0.5827801797739891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,22898,144,1.01 [0.64-1.60],0.9516857567024892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,19727,130,1.62 [1.06-2.47],0.0263211054861413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,19389,130,0.87 [0.56-1.35],0.5329848647111535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,19071,126,1.04 [0.67-1.63],0.858659874700105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,19071,126,0.92 [0.73-1.17],0.5000155589746529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,22289,137,1.04 [0.86-1.27],0.6644222241525986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,22592,141,1.05 [0.89-1.25],0.5451141503899752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22762,144,0.95 [0.79-1.15],0.5975008113876736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,22706,144,0.88 [0.64-1.21],0.4373328985620697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,19619,131,0.87 [0.59-1.28],0.4822940783742155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,19769,129,1.16 [0.65-2.08],0.6095743108883815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,19220,129,0.96 [0.75-1.23],0.7387305940980533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",19161,122,1.42 [1.03-1.95],0.031410605204153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",19738,132,1.18 [0.81-1.70],0.386051109501642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",22131,137,1.31 [0.79-2.18],0.2978500160046663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",19043,126,0.78 [0.39-1.56],0.4897028390986708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19738,132,1.27 [1.06-1.52],0.0093710652784461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",19218,129,1.01 [0.56-1.81],0.9705844643655044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,22560,140,1.12 [0.86-1.46],0.3884622293017218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,19220,129,0.91 [0.58-1.44],0.6855266978417096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,22607,141,0.99 [0.80-1.23],0.9531545545081564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,22898,145,1.04 [0.75-1.44],0.8225221770440533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22768,145,1.06 [0.87-1.30],0.5611231310715545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,19453,125,0.86 [0.70-1.07],0.1848605378515129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,22289,137,1.12 [0.83-1.51],0.4556373160373801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,19218,129,1.16 [0.97-1.40],0.1033743319114337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19727,130,1.30 [0.72-2.35],0.3871131584714964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19389,130,1.05 [0.90-1.22],0.528966223044666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",19666,129,1.10 [0.91-1.33],0.3185465606060397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,22289,137,1.26 [0.87-1.84],0.2263762331696686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,19161,122,0.93 [0.70-1.23],0.5951101735820652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,19666,129,0.98 [0.84-1.14],0.7739026376743039
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,19662,131,1.05 [0.88-1.25],0.5779176080243653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,19389,130,1.08 [0.81-1.44],0.6096510774202395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,22131,137,1.18 [0.87-1.60],0.2863206218280554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,22592,141,1.07 [0.98-1.16],0.1363081035384698
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,19762,130,1.01 [0.84-1.21],0.9468422337228029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,19071,126,0.97 [0.66-1.44],0.8956596451216069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,22268,140,1.07 [0.88-1.29],0.490356893164903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,19352,126,0.65 [0.38-1.13],0.1279506724953058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",19767,131,1.00 [0.77-1.29],0.9812158331729216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",19265,126,1.03 [0.84-1.25],0.7885689605444735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19738,132,0.97 [0.76-1.24],0.8046987164329595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,19767,131,1.12 [0.95-1.33],0.1732686517890335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,19161,122,1.34 [1.01-1.78],0.0459578560033061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,19071,126,0.95 [0.64-1.40],0.7810646442169663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,19762,130,1.02 [0.88-1.18],0.8197907419413957
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19161,122,1.35 [0.98-1.86],0.0623553077708291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,19265,126,1.04 [0.82-1.34],0.7307418370557938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,19265,126,1.01 [0.74-1.39],0.938638847492444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,19220,129,1.04 [0.87-1.25],0.6290540316049016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19220,129,0.69 [0.42-1.13],0.1379923595156098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,19738,132,0.79 [0.48-1.32],0.3725661787699942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,22268,140,0.93 [0.74-1.17],0.5367156581429638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,22706,144,0.84 [0.61-1.16],0.288635379706283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,19159,128,0.80 [0.53-1.20],0.2810067555938061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,19161,122,0.94 [0.63-1.39],0.7513477912311899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,19352,126,0.90 [0.74-1.09],0.2713594459159116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,22773,144,0.97 [0.73-1.30],0.849863296126346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,22182,139,1.03 [0.77-1.37],0.8581784513726686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,19161,122,1.31 [0.94-1.83],0.1160122713379006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,19220,129,1.10 [0.96-1.27],0.1725792008996974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22442,142,0.97 [0.75-1.25],0.7944370081515024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,19662,131,0.99 [0.73-1.35],0.951287125687151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,22696,142,0.95 [0.73-1.25],0.7295593668417882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,19179,129,0.93 [0.68-1.28],0.6570923651593374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,19228,126,1.05 [0.77-1.42],0.7725758547928735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19352,126,0.63 [0.29-1.36],0.2395106687486192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,22182,139,1.05 [0.81-1.37],0.7056186770992783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,19638,129,0.99 [0.66-1.49],0.959760708533125
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,19727,130,1.30 [0.83-2.04],0.2589999781961712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19738,132,1.03 [0.72-1.46],0.8853298313882053
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22768,145,1.61 [0.93-2.79],0.0889251709647911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,22268,140,1.09 [0.84-1.42],0.5016801765379948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,22757,141,1.19 [0.70-2.03],0.5165961557094075
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,22706,144,1.05 [0.60-1.81],0.8742154388164347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,22898,145,1.10 [0.74-1.63],0.6295416068863113
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,22632,145,0.88 [0.73-1.06],0.1813083333673299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,22801,144,1.04 [0.90-1.20],0.5907455318682564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,22268,140,0.84 [0.59-1.18],0.3164156107703783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,22627,145,1.32 [0.88-1.97],0.1801968363546706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19666,129,0.93 [0.55-1.57],0.7900414455750482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,22898,144,0.99 [0.58-1.66],0.9580054833311468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,22131,137,0.88 [0.68-1.13],0.3017397109064245
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19662,131,1.06 [0.83-1.35],0.6297400266423032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19184,129,0.73 [0.44-1.19],0.204736880646172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19666,129,1.08 [0.89-1.30],0.4420100778764796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22182,139,1.06 [0.89-1.27],0.5188906621959508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,19161,122,1.27 [0.86-1.87],0.2241841708290521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,19161,122,1.30 [1.04-1.63],0.0195509018000661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,19218,129,0.75 [0.43-1.31],0.3170807494009759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,22662,142,1.49 [0.90-2.46],0.1239074648181631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,22768,145,1.88 [1.25-2.84],0.0026014449234862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19218,129,1.10 [0.77-1.57],0.5886297421002475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,19218,129,1.49 [1.01-2.20],0.043536654508553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,22052,137,1.18 [0.82-1.70],0.3724920560976384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,19389,130,1.11 [0.91-1.34],0.3175197243720456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,22768,145,1.06 [0.75-1.50],0.7371663486091179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,22801,144,0.80 [0.47-1.36],0.4101259119266871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,19662,131,0.97 [0.83-1.13],0.6985779988149707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,19738,132,0.86 [0.39-1.87],0.6948678136800165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,19769,129,1.07 [0.84-1.36],0.5829435294129865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,22946,144,0.86 [0.50-1.48],0.5840104404906916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,19218,129,0.93 [0.76-1.14],0.4942822226711304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22660,145,1.00 [0.86-1.17],0.9922640124007976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22268,140,0.91 [0.69-1.19],0.4820191622810632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,19265,126,0.97 [0.77-1.22],0.7903448889802109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,19738,132,1.18 [0.87-1.60],0.2896969517618138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19161,122,1.07 [0.84-1.36],0.5926679880623547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19389,130,0.76 [0.51-1.13],0.1712645726014683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,22182,139,0.95 [0.70-1.30],0.7685545976932225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19666,129,1.11 [0.94-1.31],0.2181961650852669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,19161,122,1.23 [0.97-1.57],0.0894143049659847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,19161,122,1.09 [0.71-1.65],0.700821964319807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,22547,142,1.75 [0.55-5.55],0.3438030226408559
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,19767,131,1.14 [0.68-1.92],0.6218063779163372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,19727,130,1.41 [0.71-2.78],0.3223979155036076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,18870,123,0.86 [0.49-1.49],0.5797999903328115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,22680,141,1.12 [0.78-1.62],0.5430358379632858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,22706,144,1.02 [0.84-1.24],0.8124387235182816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,22182,139,0.81 [0.59-1.12],0.2027155008360143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,19265,126,1.12 [0.78-1.61],0.5393525455666833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,19698,131,1.09 [0.87-1.37],0.4318687093789977
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,19220,129,0.93 [0.72-1.22],0.6120812661971442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,19159,128,1.15 [0.85-1.56],0.3678540725178897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,19218,129,1.91 [0.97-3.78],0.0614803107841782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,22734,144,0.39 [0.21-0.75],0.0046385843915724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,19591,131,0.97 [0.76-1.22],0.7697275820808789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22547,142,0.94 [0.76-1.16],0.5408452754535182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,19071,126,0.60 [0.35-1.03],0.0636807426426103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19738,132,1.18 [0.96-1.46],0.1192400998500289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,22706,144,1.50 [0.82-2.75],0.1885213633764076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,19161,122,1.14 [1.00-1.30],0.0450393604213918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",22131,137,0.90 [0.66-1.23],0.4979449824110583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",19161,122,1.04 [0.67-1.62],0.8448640754109469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",22131,137,0.92 [0.68-1.24],0.5873278450235733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,22967,143,0.94 [0.36-2.44],0.8938808907793906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,19762,130,0.99 [0.45-2.18],0.9774192383760244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,22967,143,0.77 [0.50-1.18],0.2240253864268523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,19425,128,0.99 [0.57-1.69],0.9573194643796892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,22696,142,1.36 [0.85-2.16],0.2002838527612085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,19218,129,1.12 [0.69-1.83],0.6489943005373627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,19218,129,0.97 [0.82-1.14],0.7059871934451059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,19767,131,1.27 [0.88-1.83],0.1951991689122023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22289,137,0.99 [0.88-1.11],0.8662811552812626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,22660,145,1.27 [0.91-1.77],0.1567511261599906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,19161,122,1.40 [0.98-2.00],0.0681595862328331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,22182,139,1.05 [0.89-1.24],0.5662638266561273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,22706,144,1.14 [0.78-1.65],0.5021372312315371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,19762,130,1.01 [0.60-1.70],0.9675351291886988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,22696,142,0.66 [0.42-1.05],0.0820247710828297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,22898,144,0.97 [0.78-1.21],0.7829141441760981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,22696,142,0.90 [0.53-1.53],0.6909107566996133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,19769,129,1.09 [0.90-1.31],0.3800989762472616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,19738,132,1.17 [0.79-1.75],0.4359853788366522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,22800,141,1.13 [0.67-1.91],0.6539306079430782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,22706,144,1.02 [0.61-1.69],0.9525007396019772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,22268,140,0.99 [0.74-1.34],0.972024475192338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,19220,129,1.07 [0.68-1.67],0.7754658399354878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,22898,145,0.99 [0.80-1.23],0.9262920645596728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19767,131,1.14 [0.91-1.43],0.2495078434345954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,19727,130,0.82 [0.46-1.44],0.4841037311684306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,22630,145,0.99 [0.84-1.17],0.9226945222473004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,22768,145,1.04 [0.81-1.33],0.7632639308858523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,22660,145,1.20 [0.81-1.78],0.371409181467794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,22182,139,0.96 [0.65-1.43],0.850412753459569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,22696,142,0.95 [0.53-1.71],0.8727661621410395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,22898,145,0.97 [0.50-1.89],0.9248561767047868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22696,142,0.95 [0.81-1.10],0.4763288986868063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,22660,145,1.02 [0.86-1.22],0.7888851669013697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19662,131,0.92 [0.76-1.11],0.3674092779214519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,22856,143,1.17 [0.79-1.73],0.4451245405088891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,22946,144,1.07 [0.84-1.35],0.586424502692717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19265,126,1.20 [0.68-2.14],0.5270804774033372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19161,122,0.85 [0.58-1.24],0.3955817359098483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,19629,128,1.10 [0.91-1.33],0.3314077036206463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22592,141,0.99 [0.76-1.28],0.9247102218145964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,22706,144,1.08 [0.81-1.44],0.5914688851846293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,19218,129,1.14 [0.93-1.41],0.2067623796690351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,19161,122,0.74 [0.40-1.36],0.3264576869210542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,19161,122,1.03 [0.64-1.66],0.9172615240118192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,22131,137,0.86 [0.57-1.31],0.4832038695384041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,19218,129,1.32 [0.75-2.34],0.3353920028819842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,22474,140,1.07 [0.85-1.36],0.544940151947316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,19738,132,0.97 [0.66-1.43],0.8746149264684211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,22101,137,0.96 [0.73-1.27],0.784194815099041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,19389,130,0.88 [0.66-1.17],0.3757103477950372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,19666,129,1.07 [0.84-1.36],0.5724506751736858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,22592,141,0.87 [0.55-1.38],0.5674698726794828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,22706,144,1.10 [0.76-1.58],0.6106841864625758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19389,130,0.94 [0.71-1.25],0.6777590150521768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,18622,120,0.87 [0.76-1.00],0.0579123558467144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,22474,138,1.00 [0.78-1.29],0.9797534010080806
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,22801,144,0.97 [0.70-1.35],0.8646778787275015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,22592,141,0.91 [0.72-1.15],0.4224301403988952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,19159,128,0.64 [0.42-0.97],0.0341848978026732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,19727,130,1.02 [0.87-1.19],0.8215089412198854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,19265,126,1.01 [0.78-1.30],0.9359505575475598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,22592,141,1.23 [0.92-1.64],0.1622104495963415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,19725,128,0.77 [0.32-1.81],0.5446471833368653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,19727,130,0.84 [0.53-1.34],0.4732704843594207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22734,144,1.44 [0.92-2.24],0.1076630235818358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,22556,144,1.05 [0.86-1.29],0.6192635242635172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,22800,141,1.05 [0.51-2.14],0.8998610799032091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,19220,129,0.88 [0.57-1.36],0.5737527699170726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,19159,128,0.95 [0.68-1.32],0.7639663576687524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,19666,129,1.11 [0.84-1.48],0.456237864314744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,19738,132,1.15 [0.88-1.49],0.2994683239344561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19265,126,1.07 [0.83-1.38],0.5994543383538642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,22898,145,1.01 [0.90-1.12],0.8880445328849191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,22583,144,1.20 [0.82-1.76],0.3369457001464203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,19161,122,1.19 [0.91-1.57],0.2080832311071215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,22268,140,0.97 [0.73-1.27],0.8036918283304488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,22101,137,1.02 [0.83-1.25],0.8646514482654815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,22547,142,1.24 [1.11-1.39],0.0001457050588241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19738,132,1.03 [0.90-1.18],0.6654626693239409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19389,130,0.94 [0.66-1.34],0.7381111489234524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22289,137,1.11 [0.85-1.45],0.4471578483440058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,19265,126,0.89 [0.59-1.32],0.5536700873174049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19033,126,0.83 [0.58-1.17],0.2814523324736352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,22131,137,1.04 [0.81-1.33],0.7549644407822899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,19218,129,1.09 [0.74-1.62],0.6560230878999562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,19563,129,1.05 [0.59-1.86],0.879492198338511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,19727,130,1.31 [0.85-2.02],0.224645238159845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,19161,122,1.04 [0.83-1.31],0.7268508190915944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,22838,143,1.13 [0.66-1.94],0.6516432828678403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,22706,144,0.96 [0.56-1.65],0.8939417093183458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,22268,140,0.79 [0.57-1.10],0.159585573786704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,19389,130,0.96 [0.76-1.21],0.7263296024601128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,22706,144,0.98 [0.74-1.29],0.8747319806823345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,22660,145,1.09 [0.86-1.38],0.4647669153138412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,19352,126,1.15 [0.80-1.66],0.4466148770567945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,19071,126,1.21 [0.69-2.10],0.5056320425515071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,22131,137,0.83 [0.61-1.14],0.2502799642247804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19666,129,0.88 [0.49-1.57],0.6601308874100998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,19159,128,0.91 [0.73-1.13],0.404974708033774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19312,125,0.96 [0.66-1.40],0.8354325760143243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,19738,132,1.09 [0.87-1.38],0.4469020319774203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,22875,143,1.00 [0.50-1.98],0.9947647496269906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,19738,132,1.30 [0.69-2.45],0.4114673853262541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,22696,142,0.93 [0.60-1.43],0.7346557437595782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,19666,129,0.91 [0.55-1.52],0.7262770461835266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,19666,129,1.42 [0.86-2.34],0.1661456584794494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,19662,131,1.34 [0.91-1.97],0.1413635844035302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,19071,126,0.97 [0.73-1.28],0.810172382825039
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,19662,131,1.16 [0.83-1.61],0.396324898189245
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,22967,143,1.04 [0.71-1.51],0.842365124922021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19666,129,1.18 [0.94-1.47],0.1465687546108302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,19767,131,1.12 [0.94-1.33],0.2129499211162475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,22866,144,1.10 [0.79-1.54],0.5719986276412257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,22592,141,0.86 [0.53-1.39],0.5404797171196589
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,22898,145,1.02 [0.79-1.31],0.8872024745563356
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,22696,142,1.20 [0.93-1.54],0.1650378111284723
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,19071,126,1.10 [0.83-1.46],0.5189814714371834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19071,126,1.03 [0.77-1.38],0.8216108357628322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19161,122,1.16 [0.91-1.47],0.2290075149486022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19352,126,1.02 [0.86-1.20],0.8484410475766744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,22967,143,0.99 [0.81-1.21],0.9282049624063828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,22801,144,0.97 [0.82-1.15],0.741758103016902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,22182,139,1.01 [0.61-1.69],0.9665123856612776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,22696,142,1.32 [0.79-2.19],0.2899507124615701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,22967,143,1.00 [0.65-1.52],0.9858251964233072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,19071,126,1.07 [0.72-1.60],0.7409964087105818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,19352,126,1.20 [0.65-2.22],0.5542987458973445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,19762,130,1.08 [0.82-1.42],0.5742415240399663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,19071,126,1.07 [0.81-1.40],0.6441996810650318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,19738,132,1.05 [0.91-1.22],0.4854522328646548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,22801,144,0.99 [0.88-1.11],0.8680194264715344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22182,139,0.92 [0.67-1.26],0.6136048301872292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,19220,129,0.77 [0.53-1.12],0.1778784582213811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19071,126,1.12 [0.88-1.41],0.3625722254067083
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,19161,122,1.14 [0.87-1.48],0.3478021004862895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19218,129,1.10 [0.75-1.61],0.6147930422995582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,22967,143,0.95 [0.49-1.83],0.8760523266515893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,22706,144,0.97 [0.75-1.25],0.8201909229698184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,22706,144,0.94 [0.58-1.53],0.805501264627485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19265,126,0.91 [0.49-1.67],0.752566124220498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,19352,126,0.85 [0.48-1.51],0.5871464150472887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,19769,129,1.21 [0.64-2.31],0.5592097846765663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,19218,129,1.11 [0.97-1.28],0.1260138089029562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,19650,126,0.97 [0.81-1.15],0.7226615829366423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,22131,137,1.06 [0.81-1.38],0.6829593450798883
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,19071,126,0.67 [0.46-0.98],0.0410077887270712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,19220,129,0.90 [0.68-1.19],0.4612878460585794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22552,141,0.92 [0.76-1.11],0.3883103615022876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,19769,129,1.16 [0.91-1.46],0.2245361960296178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19767,131,1.27 [0.95-1.71],0.1073952324448671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,22946,144,0.85 [0.46-1.59],0.6121964941262499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,22859,142,1.04 [0.74-1.47],0.8192396286930859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19531,124,1.12 [0.64-1.97],0.6820712197811055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,19161,122,0.97 [0.73-1.30],0.8576024822113257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,19220,129,0.96 [0.71-1.30],0.8105100743792448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,19218,129,0.81 [0.65-1.02],0.0767802332637043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,19738,132,1.09 [0.94-1.26],0.2636539254013231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,19666,129,0.99 [0.72-1.36],0.9689947194682428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,19071,126,0.94 [0.78-1.14],0.5454234125252004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22547,142,1.31 [0.79-2.20],0.2980511999822762
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19352,126,0.82 [0.55-1.24],0.3451148855668799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,19769,129,1.97 [1.00-3.87],0.0488038207482459
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PI3,Elafin,22395,139,0.94 [0.71-1.26],0.6968455946723994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19738,132,1.16 [0.94-1.43],0.1619591420192142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22415,140,1.36 [0.89-2.06],0.1552633646116252
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22660,145,0.90 [0.71-1.15],0.4062444195351814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22706,144,1.35 [0.78-2.35],0.2892460867943065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19218,129,1.02 [0.76-1.37],0.9089727923966084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22706,144,0.94 [0.66-1.34],0.7483905125106827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,22696,142,1.00 [0.77-1.30],0.9838430955399492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19352,126,0.97 [0.75-1.24],0.7910029966796353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,19033,126,0.98 [0.79-1.21],0.8512894129897909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,19767,131,1.75 [0.92-3.33],0.0903898482078577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,19161,122,1.07 [0.80-1.43],0.650409072809248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,22728,144,0.81 [0.64-1.01],0.0631903478379929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,19389,130,0.87 [0.69-1.09],0.2196314695669521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,22547,142,0.83 [0.66-1.06],0.1396150787988813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,22768,145,1.07 [0.61-1.89],0.8141247177315509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,22929,143,1.00 [0.71-1.42],0.9827679484938232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",22618,138,0.92 [0.71-1.21],0.5681242986458046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,22801,144,1.01 [0.85-1.19],0.9447470405453624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,22706,144,0.99 [0.63-1.58],0.9775075149656898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,22898,142,1.13 [0.84-1.53],0.4099596543667309
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,22706,144,0.95 [0.58-1.58],0.8562627452976193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,22549,143,1.41 [0.81-2.43],0.2224128906665411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",19727,130,1.00 [0.76-1.33],0.9747499182222626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19218,129,1.05 [0.73-1.50],0.7881387833247049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19727,130,1.09 [0.91-1.29],0.3558296169746267
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19727,130,1.13 [0.89-1.43],0.3310671464319601
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,19268,120,1.05 [0.48-2.29],0.9026225265582344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,22131,137,0.77 [0.48-1.23],0.2758567624535711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,22696,142,1.01 [0.71-1.42],0.963723743268778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,22696,142,1.00 [0.81-1.25],0.9800499919260842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,19697,130,1.07 [0.81-1.41],0.6521893100031372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,22880,143,0.70 [0.46-1.06],0.0958264530942812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,22182,139,0.81 [0.49-1.33],0.3973994582683791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,19727,130,1.05 [0.58-1.92],0.8675021208495123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,22660,145,1.07 [0.89-1.28],0.4758898559860665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,22865,142,0.75 [0.39-1.43],0.3812258386854967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,22630,142,0.97 [0.71-1.34],0.8646802917196017
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22591,142,0.98 [0.90-1.06],0.6301326055203766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,19161,122,1.21 [1.05-1.39],0.0100603136610942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,19161,122,1.04 [0.78-1.40],0.7678178091740071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,19220,129,1.02 [0.73-1.41],0.9269263900473098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,22092,137,1.00 [0.87-1.15],0.9908886097314116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,19769,129,1.06 [0.81-1.39],0.6855281363011376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19727,130,0.98 [0.79-1.22],0.8463539610134666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,22692,144,0.97 [0.93-1.02],0.2595781116504051
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,19265,126,1.34 [1.01-1.79],0.0416466902290576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,19159,128,1.02 [0.69-1.50],0.9267201482599582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22268,140,1.11 [0.99-1.24],0.0740843214527009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,22592,141,1.98 [0.75-5.25],0.1691577543245703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,22768,145,1.56 [0.92-2.62],0.0959560448747556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,19218,129,0.82 [0.55-1.23],0.343197006482388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19218,129,0.86 [0.47-1.56],0.6132821251318838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22592,141,1.04 [0.68-1.60],0.8509135817963551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,19265,126,0.95 [0.73-1.22],0.6794796498307019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,19769,129,0.87 [0.47-1.60],0.6594023831230292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,22289,137,1.13 [0.73-1.75],0.5836731042573149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,22801,144,0.94 [0.57-1.56],0.8125645878511067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,19762,130,1.12 [0.72-1.75],0.6206594081711096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,19645,125,0.97 [0.79-1.18],0.7533307396884884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,22898,145,0.96 [0.71-1.32],0.8177430915459969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,22702,140,1.04 [0.89-1.22],0.5949366989922522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,19389,130,0.94 [0.72-1.25],0.682858529748992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19762,130,1.01 [0.77-1.31],0.9555143111487642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,19218,129,1.21 [0.75-1.94],0.4299715396135884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,22182,139,1.54 [1.08-2.19],0.0180813973681634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,19218,129,0.85 [0.62-1.17],0.3329056129508588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,19767,131,1.10 [0.80-1.52],0.5482379581936745
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,22592,141,0.91 [0.72-1.16],0.4465971814278007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19662,131,1.09 [0.89-1.33],0.3986521424308807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22768,145,1.04 [0.90-1.22],0.5699602143148113
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19389,130,1.04 [0.84-1.30],0.7120443013034469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19738,132,1.02 [0.83-1.26],0.8409966000544501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19738,132,0.93 [0.59-1.46],0.7376511056322169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,22696,142,1.02 [0.84-1.23],0.8536346925978541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,22946,144,1.08 [0.93-1.27],0.3006476529199827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19666,129,1.04 [0.90-1.19],0.6351513591757696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,22547,142,1.03 [0.72-1.48],0.8619334781894888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,19220,129,1.06 [0.87-1.30],0.5582348467254681
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,22685,144,1.06 [0.92-1.22],0.4305683480071062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,22182,139,0.96 [0.73-1.27],0.7762020697011037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,19071,126,1.40 [0.76-2.59],0.2831316541512249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,19762,130,0.86 [0.58-1.28],0.4644543009540924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,19662,131,0.90 [0.59-1.35],0.600327861693666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,22835,143,0.84 [0.52-1.37],0.4858416228504799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,22082,141,1.03 [0.87-1.23],0.6945038043918412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,19425,124,0.87 [0.66-1.14],0.3169199784798622
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22268,140,1.18 [0.96-1.44],0.1165683262136543
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",22946,144,1.01 [0.81-1.25],0.9497458613718311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,22898,144,0.95 [0.75-1.22],0.7072727905987415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,22268,140,1.11 [0.69-1.79],0.6757031356298044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,22692,144,0.91 [0.49-1.69],0.7577353613661946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,19762,130,0.86 [0.62-1.18],0.3473009209630776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,19762,130,0.91 [0.65-1.27],0.592290242088708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22268,140,1.02 [0.77-1.34],0.8928028417164315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19220,129,1.03 [0.61-1.75],0.9147542406522788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22696,142,1.03 [0.86-1.23],0.7582110206175385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19691,130,1.01 [0.83-1.24],0.922868461050099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,22268,140,1.09 [0.79-1.50],0.6004517569520085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,19161,122,1.24 [0.93-1.65],0.1345553392945217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,19352,126,1.07 [0.94-1.23],0.3098892003583129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22182,139,0.99 [0.79-1.25],0.95628515018184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,22898,145,1.01 [0.83-1.23],0.8886952542885846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,19727,130,1.10 [0.81-1.50],0.5430766566618155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,22720,141,1.20 [0.66-2.20],0.5461548053436087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,19161,122,0.90 [0.54-1.49],0.6744414636745033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,22660,145,0.94 [0.74-1.18],0.5819327959512935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,19793,128,0.99 [0.50-1.96],0.9716221852893764
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,19211,123,0.92 [0.72-1.19],0.5434827484503495
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,19218,129,0.94 [0.65-1.38],0.7610789238864334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,19265,126,1.50 [0.97-2.32],0.066357351214045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,22757,141,1.08 [0.81-1.45],0.598868964114951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,19218,129,0.93 [0.57-1.54],0.7855394601893941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,22628,141,1.13 [0.78-1.62],0.5227056289437154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,19727,130,1.37 [0.89-2.12],0.1528411243832341
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,22616,143,1.40 [0.99-1.99],0.0594630621797766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22131,137,1.03 [0.90-1.18],0.6660712861140208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,22898,144,1.46 [0.82-2.62],0.2012621676249048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,22102,134,0.89 [0.64-1.25],0.511512401907209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,19389,130,0.88 [0.48-1.61],0.6806761569531132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,19571,129,1.17 [0.67-2.04],0.5800931854716318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,19666,129,0.90 [0.64-1.26],0.5298605268032331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,19666,129,1.06 [0.99-1.14],0.0755629798206751
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22547,142,1.02 [0.90-1.16],0.7608967072313058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,22660,145,1.01 [0.80-1.27],0.9529393355257614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,22182,139,0.92 [0.66-1.30],0.64663282162625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,19071,126,1.29 [0.76-2.21],0.3428534325936413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19738,132,1.29 [0.95-1.76],0.1050306837079483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19220,129,0.94 [0.69-1.29],0.7135032957985799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22592,141,0.91 [0.69-1.19],0.4812731629848175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,22517,142,1.01 [0.68-1.50],0.9497288001136964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,22435,142,0.93 [0.63-1.40],0.7429396850004041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,22660,145,0.85 [0.64-1.14],0.2817273812514021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,19218,129,0.92 [0.68-1.24],0.5669365114001654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,22660,145,1.02 [0.88-1.18],0.7886031367891145
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,22182,139,1.15 [0.90-1.47],0.2667299924718396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18660,121,1.08 [0.91-1.28],0.3847738062151568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22131,137,0.89 [0.54-1.48],0.65226047707557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,22497,140,1.23 [0.74-2.03],0.4253574040034478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,19067,128,1.17 [0.86-1.60],0.306938933871661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,19767,131,1.12 [0.92-1.37],0.26868360711681
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,19220,129,1.14 [0.93-1.40],0.2078248660582893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22660,145,1.08 [0.76-1.54],0.6566019942670169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,22131,137,1.46 [0.99-2.14],0.0572301328186628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,22289,137,1.00 [0.74-1.36],0.9907509369528666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,19218,129,1.10 [0.82-1.48],0.5319921423558431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22547,142,1.05 [0.87-1.26],0.6421854844312236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22762,144,1.05 [0.88-1.24],0.6008659768153108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19180,129,0.96 [0.60-1.53],0.8560787720070224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19767,131,0.87 [0.49-1.56],0.6458467801390052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,19762,130,0.95 [0.45-2.01],0.8850966778235041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,22967,143,1.26 [0.75-2.10],0.3866052809788193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,19666,129,0.98 [0.69-1.40],0.9174144925889824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19666,129,0.71 [0.31-1.63],0.4225641040067193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22623,145,0.56 [0.30-1.03],0.0604092805439936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22468,142,1.46 [0.92-2.32],0.1039421707888891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,19727,130,0.96 [0.60-1.54],0.8688757727271157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,22967,143,1.25 [0.68-2.30],0.4739124045013102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19767,131,0.92 [0.55-1.53],0.7413350291307841
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19352,126,1.08 [0.81-1.43],0.5883608651942374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,22040,136,1.01 [0.77-1.34],0.93106841360265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,19389,130,0.79 [0.51-1.22],0.2925630177724032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,22660,145,1.39 [1.00-1.93],0.0495487812450696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,22786,144,1.03 [0.90-1.17],0.7096798800550097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,22898,145,1.47 [1.01-2.14],0.0443330762342097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,19662,131,0.80 [0.56-1.15],0.2332605907759151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,22131,137,0.93 [0.69-1.25],0.6118459144449353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,19265,126,0.71 [0.45-1.11],0.1333720702361785
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,19161,122,1.04 [0.87-1.24],0.7059047907402827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,19793,128,1.10 [0.85-1.43],0.4755162167738643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,22597,142,0.95 [0.68-1.34],0.7699759060517243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,22737,142,1.28 [0.74-2.22],0.382620525898226
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,19388,127,1.10 [0.77-1.56],0.6083963296664382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,19767,131,1.33 [0.99-1.79],0.0607585557151233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,19767,131,1.04 [0.89-1.22],0.5949010324190622
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,19767,131,1.05 [0.85-1.29],0.6524600680094824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,19662,131,0.92 [0.69-1.21],0.5409073806584038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,19161,122,1.05 [0.81-1.37],0.7040722181549453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,22268,140,1.16 [0.99-1.37],0.0649266062232196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,19161,122,1.04 [0.87-1.25],0.6526575091199641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19159,128,1.04 [0.78-1.39],0.7769462975379987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,19662,131,0.99 [0.68-1.45],0.9599821799161844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,22660,145,1.14 [0.85-1.52],0.3771496870081503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,22131,137,1.30 [1.01-1.67],0.0443879947846351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,19352,126,1.01 [0.81-1.26],0.9373278114022912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,22182,139,1.21 [0.97-1.52],0.0895666749458328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,22268,140,0.95 [0.74-1.22],0.6816427459920282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,19220,129,1.08 [0.88-1.34],0.454623848047614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,22182,139,1.08 [0.79-1.48],0.6257307106851009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,19389,130,0.92 [0.66-1.28],0.6165103105596526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,19218,129,1.55 [0.93-2.59],0.0946724653788969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,19662,131,1.06 [0.77-1.46],0.7321451564843404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,19265,126,0.99 [0.72-1.36],0.9489397648986836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,19159,128,1.20 [0.73-1.96],0.4767239761198159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,22182,139,1.03 [0.76-1.39],0.8692164550262452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,19218,129,0.75 [0.55-1.03],0.0749829593851162
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,19389,130,1.02 [0.74-1.40],0.9158483046763908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,22182,139,0.93 [0.59-1.48],0.7604960766495901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,22800,141,1.23 [0.90-1.67],0.1902455618614126
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,22131,137,1.09 [0.70-1.70],0.7002344632893274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19071,126,0.88 [0.59-1.31],0.5250246671343237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,22182,139,0.88 [0.66-1.18],0.4082412518967893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,19738,132,1.11 [0.71-1.72],0.6465713428454257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,22156,140,0.96 [0.71-1.28],0.7627574364211632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,19738,132,1.15 [0.93-1.42],0.1990441328883716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,19161,122,1.14 [0.83-1.57],0.4269093509448785
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,19071,126,1.07 [0.75-1.53],0.7175388704843776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,19220,129,0.91 [0.70-1.20],0.507162360522454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,22592,141,0.93 [0.76-1.14],0.5013056535028843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,22592,141,0.95 [0.72-1.25],0.7170648348529316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,19666,129,0.99 [0.75-1.31],0.9404695454452914
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,19218,129,0.98 [0.75-1.27],0.8576826941743535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,19265,126,1.01 [0.86-1.20],0.8645061034501222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,19662,131,1.12 [0.85-1.49],0.4198292989878889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,22289,137,0.96 [0.68-1.36],0.8319862646550849
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19265,126,1.36 [0.58-3.20],0.4846922231780773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,19738,132,1.10 [0.85-1.42],0.4795278703739988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,22537,141,1.14 [0.86-1.53],0.3653429324121142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,22967,143,1.01 [0.78-1.31],0.9172445270958722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,22967,143,0.93 [0.72-1.18],0.5321210552717219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,19662,131,0.87 [0.57-1.33],0.5202593396544001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,22734,144,0.90 [0.66-1.22],0.500384336701033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,19218,129,1.22 [0.93-1.60],0.155692872492679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,22706,144,1.12 [0.65-1.94],0.6732582630699151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REN,Renin,22696,142,1.19 [0.98-1.44],0.0775244139366277
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,19218,129,1.39 [0.96-2.03],0.0837654596533752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,19071,126,1.11 [0.70-1.75],0.6666647656263907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22592,141,1.08 [0.75-1.56],0.6753450025523414
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RETN,Resistin,22627,140,1.00 [0.70-1.43],0.9937285007963992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",19161,122,0.91 [0.63-1.32],0.6301297783835389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,19662,131,0.92 [0.41-2.07],0.8457553855539746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,19738,132,1.11 [0.89-1.38],0.359978240346899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19389,130,1.31 [1.09-1.58],0.004152545401027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,22898,145,1.69 [1.05-2.71],0.0312743653456445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,22898,145,1.63 [0.94-2.85],0.0835951535833101
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,19738,132,1.10 [0.84-1.45],0.478629633900019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,22268,140,1.02 [0.82-1.28],0.8296849854880874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,22391,142,1.02 [0.90-1.16],0.7593711223128842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,19218,129,1.21 [0.92-1.60],0.1775701207175872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19352,126,1.04 [0.74-1.47],0.830980828029378
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,22826,144,0.99 [0.78-1.27],0.9516645183976428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,19767,131,1.08 [0.91-1.29],0.3670418964326079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19161,122,1.09 [0.87-1.36],0.4736912109373432
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,19738,132,0.99 [0.78-1.27],0.9398308793362028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,19316,126,0.89 [0.73-1.09],0.2553553880047954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,19769,129,1.59 [0.93-2.70],0.0873198137913416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,19265,126,1.07 [0.76-1.50],0.7169380512708083
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,22593,141,0.91 [0.79-1.04],0.173871937674947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,19099,125,1.49 [0.85-2.61],0.1603201818447304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,19613,128,1.24 [0.76-2.02],0.3798749593373968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,19738,132,0.96 [0.68-1.35],0.8091895262166079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,22867,143,1.65 [1.03-2.65],0.0368076166487689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19265,126,1.76 [1.09-2.83],0.0200392735940384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,19218,129,0.90 [0.58-1.40],0.6399897377140592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,19218,129,1.28 [0.87-1.88],0.2105098746939279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,19389,130,1.18 [0.95-1.47],0.134300739344746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,22182,139,0.99 [0.79-1.24],0.9605182113486788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,19389,130,1.03 [0.78-1.37],0.8358463294423366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,19265,126,1.12 [0.88-1.43],0.3585524657417938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,22734,144,1.11 [0.60-2.05],0.7273070208951523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,22898,145,1.63 [0.88-3.02],0.1177417308722596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,19265,126,1.54 [0.59-4.05],0.3803157507415775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22696,142,1.47 [0.92-2.35],0.1089240349776552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,22592,141,1.23 [0.88-1.73],0.2285245228532883
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,19218,129,1.08 [0.64-1.84],0.7705828777005783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,19389,130,1.10 [0.87-1.38],0.422549375648826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,19220,129,1.06 [0.72-1.56],0.7546879150240242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,19265,126,1.13 [0.76-1.68],0.5575870059482284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,19161,122,0.98 [0.64-1.48],0.9052128223578708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,19220,129,1.03 [0.91-1.18],0.6099492303388319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22182,139,1.06 [0.81-1.38],0.6863883542830911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22182,139,0.95 [0.76-1.19],0.6444567662735271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,19159,128,0.90 [0.75-1.08],0.2385524218818033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,22547,142,1.09 [0.71-1.67],0.6969480474564234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,22898,144,1.76 [1.06-2.92],0.0297307342200602
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,22592,141,1.13 [0.67-1.90],0.6550026783072493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,19161,122,1.05 [0.77-1.43],0.759903216583272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19738,132,1.19 [0.99-1.42],0.0651067604575709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,22898,144,1.31 [0.88-1.94],0.1856711725505447
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,22182,139,0.96 [0.83-1.11],0.5788989271412793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,22898,145,1.05 [0.84-1.32],0.653709314352239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,19161,122,1.25 [0.83-1.90],0.2841217719509862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,22514,140,0.82 [0.57-1.17],0.2674167108420114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,22387,138,0.96 [0.78-1.17],0.6527546653043702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,19218,129,0.76 [0.46-1.27],0.3037724043065689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,19738,132,0.77 [0.56-1.06],0.1109916385913689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,22101,137,0.82 [0.63-1.06],0.1226087155442708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,19662,131,1.11 [0.81-1.54],0.5157131593164751
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,22768,145,0.97 [0.75-1.25],0.810328497564481
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,19738,132,0.79 [0.54-1.17],0.2405082724510092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,22289,137,1.12 [0.86-1.44],0.4019181239556388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,19793,128,1.07 [0.65-1.76],0.783494397663456
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,19738,132,0.98 [0.54-1.77],0.944900407174734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,19159,128,1.18 [0.89-1.57],0.252286399571879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22660,145,0.96 [0.78-1.18],0.6901520816293962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,19389,130,0.98 [0.78-1.23],0.8774759663668908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,19692,131,1.07 [0.92-1.25],0.3915536636901385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19161,122,0.95 [0.58-1.55],0.8399140165108746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,19161,122,1.21 [0.91-1.62],0.1958811972020629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,19389,130,0.94 [0.72-1.22],0.63035781681285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,19738,132,0.90 [0.51-1.60],0.7223135392997186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,19724,130,1.09 [0.66-1.77],0.744764100184116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,22592,141,1.09 [0.91-1.29],0.3472783579293627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,22898,145,1.25 [0.75-2.07],0.387346393904742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,22131,137,0.96 [0.74-1.26],0.7922545314879548
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22125,142,1.19 [0.73-1.95],0.4829106573586235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,22967,143,1.19 [0.84-1.67],0.3287983958022155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,22898,145,1.45 [0.88-2.40],0.1488223019330181
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,22784,143,1.01 [0.63-1.60],0.9754418571591852
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,22734,144,1.08 [0.70-1.68],0.7216834968184904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,22728,144,0.98 [0.76-1.27],0.9017485666785272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,19161,122,0.93 [0.53-1.65],0.8162548654728023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,19352,126,0.90 [0.46-1.76],0.7508993684336314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,22762,144,0.92 [0.76-1.10],0.3336361686377082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,22268,140,0.83 [0.59-1.17],0.2849029878200332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,19159,128,0.81 [0.63-1.05],0.1187573201169564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,22826,144,0.96 [0.70-1.31],0.8040840365329975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,19159,128,0.90 [0.62-1.32],0.5994516199406088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,19220,129,1.24 [0.75-2.08],0.4041551393575546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,19220,129,1.12 [0.74-1.69],0.5917206709894254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,19159,128,0.82 [0.55-1.23],0.3462809015284402
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,19265,126,1.06 [0.71-1.60],0.7620652958334697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,22182,139,1.19 [1.01-1.41],0.0425470525633958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,19190,126,1.20 [0.85-1.69],0.3035454444006414
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,19767,131,1.24 [0.67-2.26],0.4941549232925527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,19265,126,0.99 [0.82-1.19],0.8853854980159744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,22660,145,1.04 [0.81-1.35],0.7453613474557563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCT,Secretin,19220,129,0.69 [0.47-1.01],0.0555123994818866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,22696,142,1.17 [0.80-1.70],0.4146059402064426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,22696,142,1.04 [0.75-1.44],0.8104442116801114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,19662,131,1.08 [0.93-1.25],0.3007112674751536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,19666,129,1.20 [0.96-1.49],0.1025074401860844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,19352,126,0.98 [0.62-1.54],0.93822076058355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,19265,126,1.12 [0.89-1.41],0.3420568608115151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,19265,126,1.21 [0.77-1.90],0.4160078696837704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,22967,143,0.84 [0.63-1.12],0.2274840362235899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,19793,128,1.10 [0.53-2.31],0.7918456236569902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,19793,128,0.72 [0.35-1.49],0.3745729356675568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,22757,141,1.10 [0.85-1.42],0.4747018043575177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,22660,145,0.84 [0.50-1.41],0.5055824234185118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,22696,142,1.18 [0.67-2.09],0.5620889463862817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,19352,126,1.05 [0.71-1.55],0.8158077225566706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,22592,141,0.67 [0.37-1.21],0.1807040652976336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,22898,145,1.07 [0.66-1.75],0.7811636648643085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,19218,129,1.11 [0.60-2.05],0.737862852641116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,22898,142,1.10 [0.63-1.93],0.7385881069684906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,19738,132,1.00 [0.79-1.25],0.9735968332108288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,19389,130,0.78 [0.53-1.15],0.2056105272809348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,19686,130,1.11 [0.66-1.86],0.6999224403056933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,22592,141,1.00 [0.59-1.68],0.9850284836447848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,19401,123,0.35 [0.04-3.04],0.3384098524739857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,22967,143,1.10 [0.76-1.59],0.601511629139561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,22050,139,0.97 [0.84-1.11],0.6353961318179826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,19713,128,0.67 [0.21-2.16],0.5075440048766959
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,19412,124,1.35 [0.66-2.79],0.4111678296148087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19486,125,0.95 [0.56-1.61],0.8524646083070022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,19793,128,0.56 [0.20-1.55],0.26629951554587
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,19793,128,1.75 [0.73-4.24],0.2122650006990175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22461,141,0.80 [0.64-0.98],0.0330412028230693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,22632,141,1.03 [0.87-1.22],0.7192143878998574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,22289,137,1.09 [0.80-1.48],0.6010297380014431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,22827,145,1.11 [0.87-1.41],0.4237786168304801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,22946,144,0.86 [0.65-1.13],0.2750032583058041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,22547,142,1.11 [0.71-1.73],0.6378090831245142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,19748,127,0.45 [0.15-1.38],0.1623214115319854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,19748,127,1.73 [0.93-3.22],0.084563238299483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,22967,143,0.98 [0.79-1.22],0.8672106192241382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,19767,131,1.03 [0.80-1.33],0.8098121592595112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,19486,123,1.29 [0.68-2.47],0.439721480427827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,19410,123,0.63 [0.18-2.19],0.4634203640650021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,19748,127,0.88 [0.35-2.20],0.7819604091030303
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,19389,130,1.04 [0.91-1.19],0.5625236638799844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,19309,126,0.80 [0.45-1.40],0.4295095298209437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,19666,129,1.04 [0.77-1.40],0.8077315716170712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22131,137,1.09 [0.86-1.37],0.4853322343390488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,22484,141,1.10 [0.67-1.82],0.7064128094458968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,19220,129,1.12 [0.65-1.91],0.6915050007839163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,22768,145,1.01 [0.59-1.73],0.9719777383078704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,22592,141,1.69 [0.93-3.09],0.0849021904435744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,22592,141,0.95 [0.77-1.16],0.5996491174217915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,22480,141,1.22 [0.87-1.70],0.2512914887812738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,19352,126,1.00 [0.66-1.53],0.9923900228849624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,22182,139,1.27 [1.04-1.54],0.0174155926619833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22182,139,1.28 [0.97-1.68],0.0825667597810841
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,22696,142,0.91 [0.72-1.13],0.3894349644195379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,19413,129,0.99 [0.73-1.34],0.939906919755607
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,22182,139,1.01 [0.86-1.18],0.9323858052328589
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,22660,145,0.85 [0.64-1.13],0.269015444809345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19159,128,1.13 [0.89-1.45],0.3217235786413593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,19666,129,0.99 [0.70-1.39],0.9322926610666242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,19284,130,0.95 [0.78-1.16],0.6234320418181626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,19727,130,0.99 [0.77-1.27],0.9341029961335536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,19769,129,1.07 [0.78-1.48],0.6588608747660978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,19071,126,1.11 [0.97-1.27],0.1217957670086316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,19122,122,0.78 [0.60-1.02],0.0648154955386448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,19218,129,1.13 [0.78-1.63],0.5246170457480259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,19762,130,1.67 [0.98-2.85],0.060852604186025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22762,144,1.04 [0.88-1.24],0.6139354531037566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,19389,130,1.08 [0.74-1.59],0.6818572411159531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,22731,144,0.99 [0.73-1.36],0.9744053808439758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,22801,144,0.87 [0.63-1.20],0.3985200410700869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22660,145,1.38 [0.88-2.15],0.1585486529958138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22131,137,1.04 [0.86-1.24],0.7075666967205696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22706,144,1.00 [0.88-1.14],0.974703307511152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22898,144,1.16 [0.74-1.82],0.5072443400281532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22696,142,0.80 [0.47-1.36],0.4120223114952848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19265,126,0.92 [0.63-1.35],0.6612729297140791
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,22865,144,0.86 [0.52-1.41],0.5408497856598449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,19265,126,1.50 [1.06-2.12],0.0222284072154396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22746,141,1.02 [0.78-1.32],0.9053551367408974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,22658,144,1.03 [0.74-1.43],0.8452289237087992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19218,129,0.96 [0.77-1.18],0.682796074595984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22592,141,1.00 [0.85-1.19],0.9598478923255684
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22131,137,0.93 [0.70-1.24],0.6299362337731358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22268,140,0.94 [0.71-1.23],0.6419151671629726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,22499,142,0.93 [0.76-1.15],0.5155980829738531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,22801,144,1.00 [0.87-1.15],0.9743426879222208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,19161,122,1.02 [0.67-1.55],0.9240498401627064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,19738,132,1.11 [0.94-1.31],0.2060427918988794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,22268,140,0.90 [0.70-1.16],0.4137586948728045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,22182,139,1.08 [0.72-1.61],0.7160762242374676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,22660,145,0.96 [0.74-1.24],0.7458519584650523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,22182,139,0.87 [0.66-1.15],0.3322708752480638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,19161,122,1.50 [1.01-2.23],0.0455708736617059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,19662,131,1.13 [0.90-1.42],0.2824084845636757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,22131,137,1.23 [0.99-1.52],0.0572592675611786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,19220,129,1.25 [0.96-1.62],0.1009834543620319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,22131,137,1.07 [0.87-1.33],0.5202925698433869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,19071,126,0.88 [0.65-1.21],0.4437077242374304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,19071,126,1.06 [0.76-1.47],0.7499477962258188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,22131,137,0.96 [0.61-1.52],0.8647448549890688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,22660,145,1.08 [0.83-1.39],0.5738247805369061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,19220,129,1.09 [0.88-1.35],0.4289939184502387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,19762,130,1.11 [0.78-1.56],0.5651789502750775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,19161,122,0.72 [0.56-0.93],0.0111685302284981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19352,126,1.15 [0.94-1.41],0.1743488695213972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19666,129,0.98 [0.70-1.37],0.8981160227483542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19071,126,1.18 [0.90-1.54],0.2309106131739486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,22131,137,0.87 [0.63-1.18],0.3606809010098182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,19218,129,1.38 [0.82-2.34],0.2277160414184999
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22898,144,1.30 [0.88-1.91],0.185982117433924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22289,137,1.33 [0.87-2.03],0.1836434381115206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,19389,130,0.76 [0.57-1.02],0.064308783603514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,19666,129,1.07 [0.88-1.31],0.485114468009736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,19608,130,0.85 [0.53-1.37],0.5087393923113406
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,22182,139,1.05 [0.87-1.26],0.6090268022114698
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,19662,131,0.97 [0.76-1.24],0.7931236569399426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19662,131,0.91 [0.65-1.27],0.5693156866071802
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,22592,141,1.29 [0.61-2.74],0.4986337943902925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,22131,137,1.14 [0.94-1.40],0.182465884998786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,19071,126,1.05 [0.78-1.41],0.7568977100942366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,19666,129,0.92 [0.69-1.24],0.581329335151159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,22898,144,1.07 [0.69-1.67],0.7663985651849199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,22801,144,1.08 [0.73-1.60],0.6872654651303591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,22785,145,0.91 [0.67-1.25],0.5701983251683946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,19218,129,0.79 [0.54-1.15],0.2125485438734241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22767,144,0.84 [0.67-1.05],0.1206175830818544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19662,131,1.01 [0.81-1.25],0.96025777260009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,19159,128,0.93 [0.70-1.23],0.6145407158248211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,19695,130,0.95 [0.80-1.14],0.5893125202825555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,22696,142,1.05 [0.88-1.25],0.6029436063799823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,19159,128,1.10 [0.77-1.58],0.6031281874114154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,22768,145,1.05 [0.90-1.24],0.5330189609518248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,19738,132,1.10 [0.83-1.46],0.5183148730665036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,19352,126,0.98 [0.84-1.14],0.7480261007743899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,22547,142,1.00 [0.80-1.25],0.9752878066620012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19265,126,1.59 [1.05-2.39],0.0267607350748093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',19727,130,1.11 [0.80-1.55],0.5189138812754288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,19161,122,1.08 [0.83-1.39],0.5719491832968437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,19352,126,1.04 [0.76-1.43],0.7844209948416387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,19666,129,1.24 [0.89-1.74],0.2013434846008444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,19662,131,1.08 [0.89-1.33],0.4303806494517069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,19265,126,1.27 [0.74-2.18],0.3864409522688086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,22696,142,1.04 [0.84-1.29],0.7078857620898562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],22211,138,0.95 [0.69-1.29],0.7230104740378089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",22706,144,1.10 [0.74-1.62],0.6387723563556575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,19769,129,0.87 [0.62-1.21],0.4094038102597654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,19738,132,1.14 [0.79-1.65],0.4840405756232829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,22182,139,1.25 [0.82-1.90],0.3032688608342742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,22789,144,0.86 [0.69-1.07],0.1751294046630048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,22662,142,1.00 [0.67-1.51],0.9913679158839636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,22662,142,0.90 [0.61-1.32],0.5862705624006853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19220,129,0.86 [0.60-1.25],0.438907347307677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,19711,132,1.31 [0.65-2.63],0.4449088562397821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,19220,129,1.65 [0.89-3.05],0.1119737680098935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19738,132,1.30 [0.79-2.14],0.3025923395987751
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,19738,132,0.99 [0.74-1.32],0.9486661951980556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,22768,145,1.02 [0.83-1.26],0.8454595769068974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,22684,141,1.37 [0.83-2.27],0.2159958758140342
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPART,Spartin,19352,126,1.02 [0.81-1.27],0.8943268951637637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,19767,131,1.02 [0.56-1.84],0.948269508294812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,22706,144,1.12 [0.79-1.57],0.5259604239574069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19352,126,0.57 [0.36-0.91],0.0171337728398821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,22660,145,1.16 [0.93-1.43],0.1872326593788575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,22706,144,1.19 [0.75-1.88],0.4528674885188953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,22898,144,1.07 [0.81-1.40],0.64609890311605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,19161,122,1.11 [0.74-1.67],0.6127488817282408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22639,141,1.31 [0.72-2.39],0.3722715476892828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,22801,144,1.03 [0.72-1.47],0.8680533105231827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,19666,129,0.96 [0.85-1.09],0.5607292055968967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,22547,142,1.16 [0.64-2.09],0.621024726998225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,22734,144,1.45 [0.93-2.26],0.1047625502899792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,22595,141,1.54 [1.01-2.35],0.043527478241827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,22928,143,1.12 [0.82-1.53],0.4661094630563661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19218,129,0.77 [0.51-1.18],0.2282422625514683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,19071,126,0.79 [0.55-1.13],0.1905703528878708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,19389,130,1.04 [0.85-1.26],0.7134663855898722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,19727,130,0.91 [0.72-1.16],0.4481975058667724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,22268,140,1.12 [0.95-1.31],0.1691921675292003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19159,128,1.62 [1.08-2.42],0.0186448056301282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,19727,130,1.18 [0.79-1.77],0.4255382236838582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,22728,145,1.01 [0.89-1.14],0.876840569614717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,22592,141,0.97 [0.76-1.24],0.8177196984573064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,22660,145,1.00 [0.84-1.19],0.9701022151157342
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,19767,131,1.00 [0.60-1.66],0.9871204360907972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,22131,137,1.32 [1.10-1.58],0.003039518391076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19218,129,1.07 [0.68-1.69],0.7710298548271862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22662,142,1.05 [0.91-1.21],0.5260747970681454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22757,141,1.17 [0.82-1.67],0.3881184197461266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,19071,126,0.92 [0.51-1.66],0.7810365687726312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19666,129,0.95 [0.68-1.32],0.7659193741361644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,19352,126,1.07 [0.79-1.44],0.6683162489860786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22592,141,0.96 [0.66-1.39],0.8379338109975687
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22967,143,0.82 [0.49-1.37],0.4428214702042086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19218,129,0.85 [0.56-1.28],0.434193222928982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,19762,130,0.75 [0.42-1.33],0.3245342845685156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,19662,131,1.20 [0.80-1.78],0.3734898966625957
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,22499,142,1.02 [0.81-1.29],0.8477334028254642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,19218,129,1.00 [0.80-1.25],0.9821532834650568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,22592,141,0.99 [0.89-1.10],0.852856181612839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19071,126,0.96 [0.74-1.25],0.7707267866638111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,22898,145,1.28 [0.91-1.79],0.1628666824883871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,22673,144,1.00 [0.57-1.77],0.9933960265840664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,19159,128,0.90 [0.70-1.15],0.4025771072309073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,22673,141,1.05 [0.84-1.31],0.6884052367587087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,22289,137,1.10 [0.89-1.35],0.3681788221627268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,22131,137,1.02 [0.79-1.30],0.9022330412413148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,22696,142,1.04 [0.88-1.23],0.6597098937523278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",19071,126,1.07 [0.90-1.28],0.4324643140957025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,22182,139,1.03 [0.80-1.33],0.7970891942097875
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,19220,129,1.02 [0.68-1.52],0.9383955770468264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,19727,130,1.16 [0.79-1.70],0.4434627704110669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,22592,141,1.08 [0.86-1.36],0.4920404430964018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,19218,129,0.76 [0.46-1.23],0.2612985139803442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,22182,139,0.96 [0.76-1.20],0.7025532288658721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,19218,129,1.04 [0.74-1.45],0.8257232169459243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,22660,145,1.16 [0.87-1.54],0.3188011342589357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,19738,132,1.10 [0.88-1.36],0.4114121333724166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,22182,139,1.13 [0.82-1.57],0.4573964250572594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,19666,129,1.07 [0.71-1.61],0.7526260086383063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,22182,139,1.04 [0.86-1.26],0.6759297256473411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,22898,145,0.99 [0.88-1.11],0.8493357978129638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,22660,145,0.94 [0.71-1.25],0.672544200504311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,19218,129,0.99 [0.77-1.27],0.9278012221756692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22898,145,1.25 [0.94-1.66],0.1298650168812674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",19738,132,1.05 [0.81-1.36],0.7219065694781555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,22289,137,1.07 [0.78-1.46],0.6795052893686628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,22706,144,1.10 [0.67-1.82],0.7032008733841292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,19662,131,1.32 [0.94-1.84],0.1101196158198229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19235,125,1.43 [0.86-2.37],0.167457979020614
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,19220,129,0.95 [0.72-1.25],0.6973556072315427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,19666,129,0.77 [0.46-1.29],0.3221222206070012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,19352,126,1.06 [0.78-1.43],0.7052476393417073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19159,128,0.89 [0.65-1.22],0.4845335547815469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,19727,130,1.33 [0.97-1.83],0.0763972385800649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,19767,131,1.12 [0.90-1.39],0.3254437295892111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19389,130,1.02 [0.87-1.20],0.789870016922667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,22592,141,1.04 [0.91-1.18],0.5531716994530445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,20151,121,0.92 [0.52-1.61],0.764559750622938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,19662,131,0.99 [0.64-1.52],0.9546077656358452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,22592,141,1.30 [0.86-1.97],0.2203469480040199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,19071,126,1.06 [0.81-1.38],0.6703111146907896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,19679,130,1.04 [0.72-1.51],0.8351701729434907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,22268,140,1.06 [0.85-1.32],0.6078688916122281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,19389,130,1.28 [1.05-1.55],0.0122581895280335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,22131,137,1.00 [0.83-1.22],0.962795848833042
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19220,129,1.08 [0.89-1.32],0.4453180165191047
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19662,131,1.40 [0.94-2.09],0.1023775109715753
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,19727,130,0.96 [0.74-1.26],0.7907802788504896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,22131,137,0.99 [0.71-1.37],0.9369396041526358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,22592,141,0.98 [0.83-1.15],0.7745146577288277
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,22660,145,0.96 [0.80-1.16],0.6907738156468852
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,19352,126,1.04 [0.86-1.27],0.6630797259122161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,22547,142,1.01 [0.87-1.17],0.9186409886284782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,22547,142,1.00 [0.83-1.20],0.9788760444997444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22182,139,1.02 [0.85-1.22],0.8254915027738717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,19220,129,1.25 [0.95-1.64],0.1113218992585652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,22507,141,0.98 [0.83-1.14],0.77078273111497
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,22289,137,0.98 [0.81-1.19],0.8398700971721643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,19356,126,1.09 [0.66-1.80],0.730987213188736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,22928,143,0.69 [0.42-1.15],0.1560955553128012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,19767,131,1.19 [0.72-1.98],0.4903093805549886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,19389,130,1.02 [0.77-1.36],0.8699674043904423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,19767,131,1.14 [0.64-2.02],0.6546558567602611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,22131,137,1.04 [0.93-1.15],0.5078311273111975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",19220,129,1.03 [0.68-1.57],0.8910112198963043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,19662,131,0.86 [0.65-1.13],0.2814691257053895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,22131,137,0.98 [0.82-1.17],0.8186040808771325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,19161,122,1.15 [0.78-1.68],0.4856446576474613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,22768,145,1.25 [0.63-2.47],0.5225565173807202
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,19218,129,1.13 [0.65-1.96],0.6750817744129161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,19353,130,1.03 [0.87-1.21],0.7532319505596401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,19220,129,0.91 [0.59-1.41],0.6796417092994931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,19389,130,0.82 [0.51-1.32],0.4222425086653218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,19793,128,0.70 [0.32-1.52],0.3692044930156545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,19159,128,0.96 [0.71-1.29],0.7746125490578484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,22596,144,1.12 [0.94-1.34],0.2020993434804463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,22762,144,1.24 [0.97-1.59],0.0856030178054071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,22653,141,1.24 [0.96-1.61],0.0951511331716855
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,22611,140,1.16 [0.72-1.86],0.5473479618066713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,22695,144,0.79 [0.51-1.22],0.2838556351267948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,22769,141,1.19 [0.82-1.74],0.362949453509368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,19662,131,1.04 [0.91-1.19],0.5839863683546886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,22660,145,1.13 [0.83-1.52],0.4428912131721032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,22906,144,1.05 [0.71-1.54],0.8104532760800229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,19662,131,1.10 [0.81-1.49],0.5354488824383664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22534,140,0.65 [0.37-1.13],0.126532482492399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,19218,129,0.70 [0.31-1.59],0.392222852561668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,22768,145,1.50 [0.96-2.32],0.0721890623104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,22967,143,1.03 [0.66-1.60],0.9136234551508184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22666,142,0.87 [0.71-1.05],0.1448663446932209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,19769,129,1.79 [0.96-3.35],0.0685222543767832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,19033,126,0.83 [0.66-1.05],0.1154592944949881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,22696,142,1.64 [0.97-2.77],0.0658942135465579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,22706,144,0.91 [0.59-1.38],0.6477570439579237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,22680,141,1.00 [0.72-1.39],0.9896854778901104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,22593,142,0.76 [0.46-1.26],0.2865307385648388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,22289,137,1.28 [0.86-1.88],0.2222451326728835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,19161,122,0.96 [0.82-1.13],0.6145389275968121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,19074,129,0.92 [0.55-1.54],0.7629225663255825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,19635,131,1.07 [0.88-1.29],0.4906265466499896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,22898,145,1.63 [0.98-2.73],0.0612134102176488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,22047,136,1.06 [0.94-1.20],0.34718179050181
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,22967,143,1.04 [0.73-1.48],0.838974683651171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22083,137,1.06 [0.77-1.46],0.7171240592372912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19389,130,0.99 [0.62-1.57],0.9515852287962884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22757,141,1.01 [0.72-1.42],0.9549358178313851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19767,131,1.14 [0.76-1.71],0.5219571411984412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19727,130,1.13 [0.93-1.38],0.2044738301831812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,22420,139,1.07 [0.63-1.83],0.8006791368921895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,19767,131,1.17 [0.66-2.07],0.599686968055096
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,22801,144,1.00 [0.90-1.12],0.959157696951874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,22706,144,1.21 [0.86-1.72],0.2743765051121281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,22621,142,0.99 [0.50-1.94],0.9741931343765274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,22768,145,1.03 [0.86-1.23],0.7306789019190965
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,19159,128,0.94 [0.63-1.41],0.7772905714970206
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",19389,130,0.85 [0.56-1.28],0.4322186770055219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,19218,129,1.31 [0.71-2.42],0.3811481862989657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,19389,130,1.28 [0.62-2.63],0.5088801653632833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,22946,144,0.91 [0.72-1.15],0.4315989148039106
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,19218,129,0.93 [0.51-1.71],0.8219377689582182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19220,129,1.04 [0.76-1.41],0.8050576441308813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,19389,130,1.12 [0.84-1.48],0.4448033496704093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,19161,122,0.83 [0.54-1.28],0.4013227588702367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,19161,122,1.04 [0.77-1.39],0.8136624211983648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,19666,129,1.07 [0.91-1.27],0.4097656797067961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,19662,131,1.07 [0.85-1.35],0.5542318207449761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,19265,126,1.19 [0.92-1.54],0.1840123933925981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,19738,132,1.17 [0.83-1.65],0.358121919160613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,19071,126,1.24 [0.85-1.81],0.2738385817083046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,19159,128,1.00 [0.81-1.25],0.9763206352926342
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,19686,130,0.70 [0.45-1.09],0.1182199801208765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,22592,141,0.96 [0.82-1.13],0.6425859303719033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22437,140,1.44 [0.97-2.15],0.0738154218576489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,22706,144,1.01 [0.83-1.23],0.9244436519080416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,22757,141,1.14 [0.84-1.55],0.4036380206164977
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,22248,137,1.00 [0.69-1.46],0.9901694096449634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19666,129,1.08 [0.76-1.53],0.6604337546871661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22268,140,1.07 [0.72-1.60],0.7391513132224229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19352,126,1.07 [0.82-1.39],0.6431624763143055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22547,142,1.03 [0.65-1.64],0.8900352955761105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22547,142,1.17 [0.89-1.55],0.250301156712041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22728,141,1.11 [0.82-1.50],0.4902818890978411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22946,144,1.15 [0.78-1.69],0.4870066049811266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22692,144,0.73 [0.43-1.22],0.2288310761157024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22768,145,1.44 [0.95-2.18],0.0823653489054877
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22734,144,0.77 [0.48-1.26],0.2993158343596015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22268,140,1.03 [0.71-1.49],0.8891541235551735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22734,144,1.38 [0.85-2.24],0.1916043801805353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19352,126,0.83 [0.54-1.28],0.4007194326763874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22898,144,1.44 [0.91-2.29],0.1227985798260728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22706,144,1.26 [0.76-2.10],0.3689222751418411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22706,144,1.09 [0.75-1.60],0.6538361089459886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22898,145,1.80 [1.06-3.05],0.0302661857856062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22906,144,1.23 [0.84-1.80],0.2944576241741161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22547,142,1.22 [0.95-1.57],0.1228565489795069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22898,145,1.14 [0.83-1.56],0.4143043062621683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22547,142,1.29 [0.90-1.86],0.1716207296779431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22946,144,0.73 [0.42-1.29],0.2774921779077133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22660,145,1.00 [0.79-1.28],0.9863447286385948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,22946,144,0.83 [0.50-1.38],0.4755417415307038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,22801,144,1.03 [0.59-1.79],0.9305243086380725
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22927,142,0.91 [0.52-1.59],0.7305144277647531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22547,142,1.17 [0.91-1.51],0.2110141164731514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19762,130,0.81 [0.50-1.30],0.3726154744566191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,19727,130,1.03 [0.86-1.25],0.7291929958140584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,19762,130,0.83 [0.57-1.21],0.32726902547838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",22289,137,1.00 [0.84-1.20],0.9861436337463992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,19389,130,0.81 [0.49-1.32],0.3937205639468157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,22547,142,1.41 [1.00-1.99],0.0498356258340421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,22706,144,1.17 [0.65-2.08],0.602562133004076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19767,131,1.13 [0.92-1.39],0.260109176703188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,19666,129,0.92 [0.79-1.09],0.3382256694991027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",19071,126,0.86 [0.59-1.25],0.4143996990293419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,19218,129,1.19 [0.97-1.46],0.0908909807618648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,19265,126,1.08 [0.79-1.47],0.6296325556180987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,22182,139,0.96 [0.67-1.37],0.8242941795077732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,19218,129,0.95 [0.78-1.15],0.5991277761263184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,18926,122,1.10 [0.79-1.52],0.5822539107212525
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22289,137,1.03 [0.66-1.61],0.8893726354257717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,19220,129,1.11 [0.68-1.81],0.6706676063424568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,19220,129,0.64 [0.40-1.04],0.0710029597296748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,19352,126,1.10 [0.93-1.29],0.2509229058546453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,19767,131,1.32 [0.72-2.43],0.3660417806711655
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,19161,122,1.24 [0.86-1.77],0.2436218400932844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,22182,139,0.79 [0.64-0.98],0.0355704763042993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,22548,143,0.86 [0.61-1.22],0.4045197559793652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,19389,130,1.00 [0.81-1.23],0.9911206529653436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,22131,137,0.92 [0.62-1.37],0.6723800086962604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,19161,122,0.94 [0.65-1.36],0.748077724040227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,19071,126,0.82 [0.59-1.12],0.211192820490375
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,22909,144,0.85 [0.64-1.12],0.2454002634881223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,19738,132,0.73 [0.44-1.21],0.2250010251310722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,19218,129,1.50 [0.88-2.57],0.1358712877213805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,22268,140,1.08 [0.88-1.33],0.4601642830533381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,22660,145,0.94 [0.76-1.16],0.5564666973243027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19218,129,1.06 [0.67-1.65],0.8112281840948389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19161,122,0.76 [0.49-1.17],0.2154530185557724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19389,130,1.09 [0.90-1.30],0.3738385381120943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,19762,130,0.77 [0.62-0.96],0.021556230048191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,22692,144,0.96 [0.72-1.28],0.7886446064075148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,19769,129,1.13 [0.82-1.54],0.4541186608058419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,22706,144,1.43 [0.91-2.23],0.1172609502174816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,22898,144,1.14 [0.90-1.43],0.2720875259564624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,22660,145,0.99 [0.82-1.19],0.9095611202148284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,19346,130,1.12 [0.88-1.44],0.3493733193507943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19666,129,0.93 [0.80-1.09],0.3716099708204804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,19071,126,0.75 [0.53-1.06],0.1018479734157734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,19220,129,0.79 [0.62-1.01],0.0639102483703629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,22660,145,0.94 [0.79-1.12],0.4721624130371166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,19662,131,1.03 [0.85-1.24],0.7834699933656175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,19161,122,0.82 [0.55-1.22],0.3343687712393512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,19218,129,0.86 [0.66-1.13],0.2820983833452119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,19738,132,1.11 [0.88-1.40],0.3766985553151181
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,22696,142,1.05 [0.88-1.25],0.5848767383459644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,22289,137,1.02 [0.80-1.30],0.8692399413697978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,19161,122,1.19 [0.78-1.83],0.4232226589000399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,22289,137,1.64 [1.11-2.44],0.0138433617808114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,19161,122,1.04 [0.75-1.44],0.833807685552538
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,19159,128,0.92 [0.75-1.13],0.4085270174232251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,19666,129,0.83 [0.70-0.98],0.0272860429240652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,19218,129,1.17 [0.79-1.74],0.4311155205657708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,22093,137,1.07 [0.88-1.31],0.4816242415038269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,19220,129,0.84 [0.59-1.21],0.3545095691280612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTN,Titin,19161,122,1.05 [0.82-1.36],0.6783568945845038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,19566,126,0.80 [0.41-1.57],0.5233873603925594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,19159,128,1.02 [0.55-1.88],0.9565641458854842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,19762,130,1.08 [0.89-1.32],0.437022784413116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,19389,130,1.08 [0.88-1.32],0.4498352094059114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,22547,142,1.04 [0.87-1.23],0.6842155949023951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,19426,127,0.98 [0.67-1.44],0.9282579521289136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,22768,145,1.27 [0.75-2.15],0.3704458496719733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,22898,145,1.11 [0.90-1.38],0.3232566695068661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,19727,130,1.17 [0.87-1.58],0.3048486426489746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,19122,127,0.88 [0.72-1.08],0.2346203353677663
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22706,144,0.99 [0.72-1.36],0.9534674700608464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,22550,142,1.00 [0.80-1.26],0.9667337660931176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,22696,142,1.26 [0.75-2.14],0.3860117625686207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19218,129,1.12 [0.85-1.47],0.4241569589608168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,22592,141,0.67 [0.44-1.02],0.0627874858889657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,19662,131,1.37 [0.82-2.28],0.2335109276204811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19767,131,1.04 [0.79-1.37],0.764077941605666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19218,129,1.01 [0.76-1.34],0.9602260217601488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,19161,122,1.22 [0.89-1.67],0.2216340034213939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,19352,126,0.98 [0.77-1.26],0.9025808879033876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19666,129,1.03 [0.91-1.16],0.6435856541725029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,19161,122,1.09 [0.93-1.27],0.2988819395881823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,19161,122,1.09 [0.69-1.71],0.7183220958894828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,22547,142,1.31 [0.89-1.93],0.1686306574106006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,22902,142,1.13 [0.85-1.49],0.4089386804503327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,19218,129,1.59 [0.89-2.86],0.1196840735059071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,19071,126,1.11 [0.84-1.48],0.4623352425076529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,19662,131,1.01 [0.63-1.65],0.9533438897814754
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,19767,131,1.10 [0.92-1.32],0.2744663495693056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,19159,128,0.83 [0.58-1.18],0.3004271871256722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,19361,130,0.90 [0.64-1.26],0.5301194439228403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,19352,126,1.10 [0.86-1.40],0.4469313167987251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,19220,129,1.04 [0.82-1.32],0.7329522529479138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,22592,141,0.97 [0.82-1.14],0.700642789589454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19662,131,1.05 [0.83-1.32],0.7040347430028169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19727,130,1.14 [0.76-1.71],0.5204712730099128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19161,122,0.87 [0.69-1.09],0.2287883121070489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22289,137,1.05 [0.90-1.23],0.5136837089570843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,22182,139,1.13 [0.86-1.47],0.3775052756559912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,22289,137,1.04 [0.80-1.35],0.7905775505193069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,19218,129,1.04 [0.86-1.26],0.7116642146727588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22660,145,1.07 [0.89-1.27],0.4867820392788895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,22307,138,1.58 [0.91-2.72],0.1019172672323721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,19769,129,1.13 [0.90-1.43],0.2832758254008002
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22592,141,0.70 [0.33-1.50],0.3604253937852635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,19159,128,1.10 [0.93-1.30],0.2777608244307638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,22720,141,1.36 [0.79-2.35],0.2733863125247324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,22898,145,1.06 [0.66-1.73],0.8009349886028108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,19071,126,1.09 [0.91-1.31],0.3385819249439666
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,22877,144,0.88 [0.68-1.14],0.3452040673853164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,19218,129,1.16 [0.64-2.09],0.6300591162027909
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,22768,145,0.93 [0.72-1.21],0.5900640400252115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,22906,144,1.00 [0.64-1.54],0.9891037591313592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,19738,132,1.58 [0.93-2.69],0.0915929234607394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,22289,137,0.91 [0.81-1.02],0.1044803499534281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,19265,126,1.14 [0.60-2.17],0.6823064957928522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,19767,131,1.39 [0.89-2.17],0.150090607200739
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,22592,141,0.89 [0.72-1.09],0.2611078038058775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,19769,129,0.85 [0.68-1.06],0.1383098222926475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,22592,141,1.16 [0.83-1.62],0.3895118665111758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19389,130,1.03 [0.80-1.32],0.8105755596746749
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,22592,141,0.98 [0.81-1.18],0.8129278752686633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,19662,131,1.06 [0.89-1.26],0.5410986030166413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22592,141,1.04 [0.86-1.26],0.6624659726087022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,19662,131,1.21 [0.80-1.83],0.3663002843910049
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19161,122,1.47 [0.94-2.32],0.0929160680616357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,19662,131,1.22 [0.94-1.59],0.1370735448415687
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,22673,144,0.96 [0.65-1.41],0.8318852319280335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22661,142,1.09 [0.87-1.38],0.4561855536274418
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,19727,130,1.32 [0.87-2.00],0.1950222548440085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,22131,137,1.04 [0.76-1.42],0.8128924913085778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,19389,130,1.03 [0.70-1.51],0.8965532658257063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22289,137,1.01 [0.77-1.31],0.9667723417602392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22898,145,1.00 [0.81-1.22],0.9795370205856672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22182,139,1.60 [1.03-2.46],0.0345165416744327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19352,126,0.93 [0.69-1.25],0.6409653560521192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,22859,144,1.23 [0.87-1.74],0.2393041901854533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,19071,126,1.08 [0.89-1.30],0.4376726362915657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22463,141,1.87 [1.28-2.73],0.0012846173438735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,19738,132,0.93 [0.64-1.36],0.7008779223599296
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,22967,143,1.07 [0.88-1.31],0.5058929938302141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22706,144,0.81 [0.55-1.20],0.3027710942373776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,22268,140,0.93 [0.74-1.16],0.5196550374443514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,22289,137,1.01 [0.86-1.19],0.8970473657915167
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,22131,137,1.04 [0.87-1.25],0.6658018790112779
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,19727,130,1.08 [0.87-1.34],0.4639250438138488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,19218,129,0.87 [0.64-1.18],0.3814993819348437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,19662,131,0.93 [0.58-1.50],0.7649258878326596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,19276,130,0.88 [0.62-1.25],0.4638734576920156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,22870,144,0.97 [0.77-1.21],0.7747531751042216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21523,133,2.34 [1.69-3.23],2.615212461405864e-07
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22484,141,1.23 [0.86-1.77],0.2561823279852099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22734,144,1.56 [1.03-2.37],0.0350654702830281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,22898,144,1.03 [0.68-1.58],0.8784805798345018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,22268,140,0.54 [0.31-0.95],0.0314887991323339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22547,142,0.98 [0.74-1.29],0.8644642720808358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,22898,144,1.13 [0.89-1.44],0.3117977298197725
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,22852,142,0.94 [0.57-1.56],0.8033490759952869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,19218,129,1.06 [0.79-1.42],0.7138068806541207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,22768,145,0.92 [0.78-1.09],0.3513557197860182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,22131,137,0.89 [0.58-1.36],0.5941889210639253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,19727,130,1.27 [0.68-2.36],0.4494166738357743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19666,129,1.10 [0.98-1.24],0.1023931337217243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,22592,141,0.97 [0.85-1.11],0.6359531725170966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,19662,131,1.05 [0.63-1.75],0.8377364732682222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,19161,122,1.00 [0.76-1.31],0.9809277803455634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,22268,140,1.08 [0.91-1.29],0.3853183118047804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,19352,126,1.09 [0.86-1.37],0.4732009568567573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,19218,129,1.51 [0.89-2.57],0.1306357173115911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,19218,129,0.79 [0.49-1.27],0.3280884020766599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,22182,139,0.94 [0.76-1.18],0.607405030599609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,22289,137,0.95 [0.66-1.39],0.803593303530997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19161,122,0.86 [0.62-1.18],0.3366871091526956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,19666,129,1.13 [0.94-1.37],0.187494441920232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,19727,130,0.90 [0.52-1.57],0.7093520543585993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,19218,129,0.80 [0.48-1.33],0.3863197416025886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,19389,130,1.05 [0.81-1.36],0.7178860173895033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,19662,131,1.20 [1.00-1.43],0.0468630076385918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,19666,129,1.10 [0.87-1.40],0.4140177383943372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19662,131,1.31 [1.00-1.72],0.0501554237847889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,19265,126,1.06 [0.99-1.13],0.1001316853701989
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,19071,126,0.98 [0.59-1.63],0.9501975206919052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,19159,128,1.10 [0.95-1.29],0.200888016443683
